Establishing the European Standard set of forensic genetic markers in routine casework: population studies and next generation kit internal validation by Andreia Filipa Cabral de Melo
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Andreia Filipa Cabral de Melo 
Forensic Genetics 
Biology 
2012 
 
Supervisor 
Cíntia Alves, Head of the Genetic Identification and Parentage Testing Unit, 
Institute of Molecular Pathology and Immunology of the University of Porto 
Co-supervisor 
António Amorim, Senior Professor, Faculty of Sciences, University of Porto 
Establishing the 
European Standard 
Set of forensic 
genetic markers in 
routine casework: 
population studies 
and next generation 
kit internal 
validation 
Todas  as  correções  determinadas  
pelo júri, e só essas, foram efetuadas. 
 
O Presidente do Júri, 
 
 
 
 
 
Porto, ______/______/_________ 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Dissertação de candidatura ao grau de Mestre 
em Genética Forense apresentada à 
Faculdade de Ciências da Universidade do 
Porto 
O presente trabalho foi desenvolvido sob a 
orientação científica da Drª. Cíntia Alves e do 
Professor Doutor António Amorim e realizado 
no IPATIMUP 
 
 
Thesis presented for the degree of Master in 
Forensic Genetics, at the Faculty of Sciences, 
University of Porto 
The present work was developed under the 
scientific supervision of Dr. Cíntia Alves and 
Professor António Amorim at IPATIMUP 
 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
i 
 
 
AGRADECIMENTOS 
 
À Cíntia, que ao longo de todo este caminho me guiou, orientou, me deu bases e 
conhecimentos para que eu pudesse realizar o meu trabalho, que esteve sempre lá, a 
qualquer hora, em qualquer dia… um grande obrigada por toda a confiança, 
compreensão e dedicação neste período! Obrigada pelo apoio, pela palavra amiga e 
entusiasmo no momento certo. 
Ao Professor Amorim, que não só me permitiu estar presente neste Mestrado, como 
também me proporcionou a possibilidade de poder dedicar-me à área forense, no 
decorrer deste projeto. Um muito obrigada pela disponibilidade e pela opinião e 
palavra certa que me permitiu muitas vezes reajustar o meu pensamento crítico em 
relação a alguns assuntos. 
Ao IPATIMUP, onde realizei todo o meu trabalho e onde me foi permitido conhecer e 
experimentar técnicas, procedimentos e análises forenses sem as quais o meu 
trabalho não faria qualquer sentido. 
Agradeço ao grupo de Genética Populacional, nomeadamente às minhas “amigas de 
Mestrado” sem as quais este percurso não teria tido a mesma beleza. À Sofia, à 
Marisa, à Catarina X., à Ana, à Lídia e às duas meninas de Aveiro, Inês e Catarina S. 
um muito obrigada com muita amizade, pois tornaram este caminho inesquecível. 
Aos meus pais, em especial à minha querida mãe, minha melhor amiga, que sempre 
me apoiou em qualquer passo ou caminho do meu percurso, sem nunca duvidar do 
meu talento. Espero orgulhar-te para sempre. À minha pequenina, minha maninha, 
obrigada pelo teu sorriso quando o dia não tinha corrido pelo melhor. Obrigada à 
minha linda família que mesmo longe me apoia e acarinha. 
À Rosa e ao Joaquim, que fazem parte da minha família e que sempre me 
acarinharam. 
Por fim, ao meu amigo, companheiro de sempre e para sempre, à minha metade, 
agradeço-te toda a compreensão, carinho e apoio incondicional. Sem ti não poderia ter 
chegado até aqui, pois seja qual for o desafio, iremos sempre ultrapassá-lo…juntos! 
 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
ii 
 
 
SUMMARY 
 
National DNA profile databases are becoming the most powerful tool in forensic 
investigation and genetic identification. Overtime, European countries have been 
debating on standardization concerning the number and type of STR markers to be 
included, so that information exchange can be achieved in a more fruitful manner. The 
ESS (European Standard Set) core of loci was created consisting of five STR markers 
and this new set also accomplished the necessity to implement new markers which 
would be amplified in smaller amplicons, in order to solve increasingly common 
casework involving degraded DNA samples. This European request coincided with 
IPATIMUP’s laboratory of genetic identification and kinship analysis necessity for more 
genetic information in order to obtain sounder conclusions in deficient paternities or in 
more complex kinship cases. Until now, the markers used on a routine basis in 
IPATIMUP´s laboratory are analysed through two multiplex systems, Identifiler Plus 
(Applied Biosystems) and Powerplex 16 HS (Promega), which amplify a total of 17 
STRs and share 13 loci between them. However, when more genetic information was 
required, the laboratory accessed to an “in-house” multiplex, composed of 4 loci (CD4, 
F13A01, FES and MBPB), in order to obtain further autosomal information. These 
markers not only lack high polymorphism content but are in disuse by the scientific 
community. Consequently, participation in proficiency testing with these markers will 
not yield consensus, and so external quality control will not be accomplished. 
Therefore, the need for a new set of STRs became demanding, which also would 
preferably be more informative than the aforementioned “in-house” loci.  
The ESSplex Plus kit is a next generation kit developed by Qiagen Company that 
contains the five new loci specified in the recently expanded European Standard Set 
(ESS) together with the remaining markers usually used in routine casework. In this 
work an internal validation study of ESSplex Plus kit was performed with evaluation of 
critical parameters such as system sensitivity, precision, contamination and mixture 
analyses, and degradation studies. A population genetic study was initially performed 
in order to first validate this new set of markers in the Portuguese population. Each new 
marker (D1S1656, D2S441, D10S1248, D12S391 and D22S1045) was characterized 
in terms of allele frequency estimation, Hardy-Weinberg equilibrium test and 
parameters of forensic interest; as well as a segregation analysis. Moreover, another 
next generation system, NGM kit (Applied Biosystems), was also used for a 
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concordance study (ESSplex Plus and NGM share the same loci) and for performance 
comparison purposes. 
This internal validation study is crucial for understanding the performance, limitations 
and potentials of this system in the Portuguese population, applied in a particular 
laboratory with specific routine casework and procedures. In our investigation, 370 
individuals were sampled, comprising 120 true trios (125 fathers, 125 mothers and 120 
sons/daughters) for population and segregation studies. Moreover, for the kit 
performance studies, nine technical and administrative personnel from IPATIMUP 
Diagnostics were also sampled for different biological material in distinct sampling 
devices. The methodology adopted and used was adapted from the available literature 
on internal validation cases and also from SWGDAM guidelines. 
No deviations from Hardy-Weinberg equilibrium were detected for the five new loci in 
the Portuguese population. Comparison of our sample with other available European 
samples generally revealed no significant allele frequency differences. 
No genotyping inconsistencies were observed between ESSplex Plus and NGM kits in 
the concordance study, as well as between all four multiplex systems concerning the 
shared markers. 
Comparing with the other systems evaluated (NGM, Identifiler Plus and Powerplex 16 
HS), ESSplex Plus kit revealed higher sensitivity and a better detection of degraded 
DNA information.  
Our results confirm the multiplex robustness regarding PCR chemistry and the 
improved performance requested by the European forensic community for typing 
degraded samples so as to ensure data quality and sensitivity. The five new ESS 
markers are suitable for application in our laboratory’s routine casework as well as the 
ESSplex Plus kit as an option to be introduced in future routine casework. 
 
Key-words: 
ESSplex Plus, Internal Validation, European Standard Set, STRs, Next generation kit, 
Population studies, Forensic genetics. 
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RESUMO 
 
As bases de dados nacionais de perfis genéticos estão a tornar-se uma poderosa 
ferramenta, ao nível da investigação forense e de identificação genética. Os países 
Europeus têm debatido a uniformização no que respeita ao número e tipo de 
marcadores STR a serem adotados, para que a informação partilhada entre eles 
possa ser obtida mais facilmente. Foi criado o ESS (European Standard Set), 
constituído por cinco marcadores STR. Este novo conjunto trouxe também a 
possibilidade de implementar novos marcadores com amplicões de menor tamanho, 
de forma a resolver casos que envolvam amostras de DNA degradadas, cada vez 
mais comuns na rotina laboratorial. Esta solicitação Europeia coincidiu com a 
necessidade de mais informação genética por parte do laboratório de identificação 
genética e análise de parentescos do IPATIMUP, para que conclusões mais sólidas 
fossem obtidas em casos de investigação de paternidade deficientes ou em 
parentescos mais complexos. Até agora, os marcadores utilizados na rotina do 
laboratório do IPATIMUP eram analisados através de dois sistemas em multiplex, 
Identifiler Plus (Applied Biosystems) e Powerplex 16 HS (Promega), que amplificam 
um total de 17 STRs e partilham entre si 13 loci. No entanto, quando era necessária 
mais informação genética, o laboratório acedia a um multiplex “in-house”, composto 
por 4 loci (CD4, F13A01, FES e MBPB), de forma a obter mais informação de cariz 
autossómico. Estes marcadores não só carecem de um elevado conteúdo polimórfico 
mas estão também em desuso pela comunidade científica. Consequentemente, a 
participação em testes de proficiência com estes mesmos STRs não iria gerar 
consenso, sendo que deste modo o controlo externo da qualidade não seria 
conseguido. Deste modo, a necessidade de um novo conjunto de STRs tornou-se 
essencial, sendo que este seria ainda mais informativo do que os mencionados loci 
“in-house”. 
O ESSplex Plus é um kit de nova geração desenvolvido pela companhia Qiagen, que 
contém os cinco novos loci especificados no recentemente expandido European 
Standard Set (ESS), juntamente com os restantes marcadores usualmente utilizados 
na casuística de rotina. Neste trabalho, foi realizado um estudo de validação interna do 
kit ESSplex Plus, com a avaliação de parâmetros críticos como a análise da 
sensibilidade, precisão, contaminação e mistura, bem como estudo de degradação. 
Foi inicialmente realizado um estudo de genética populacional de forma a validar 
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primeiramente este novo set de marcadores na população Portuguesa. Cada um dos 
novos marcadores (D1S1656, D2S441, D10S1248, D12S391 e D22S1045) foi 
caraterizado no que diz respeito à estimativa de frequências alélicas, equilíbrio de 
Hardy-Weinberg, parâmetros de interesse forense, bem como análise de segregação. 
Além disso, foi utilizado outro sistema de nova geração, o kit NGM (Applied 
Biosystems), para o estudo de concordância (ESSplex Plus e NGM partilham os 
mesmos loci) e para comparação de performances.  
Este estudo de validação interna é crucial para o entendimento da performance, 
limitações e potencial deste kit na população Portuguesa, aplicado a um laboratório 
particular com uma casuística de rotina e procedimentos específicos. Na nossa 
investigação, 370 indivíduos foram amostrados, compreendendo 120 trios verdadeiros 
(125 pais, 125 mães e 120 filhos/filhas) para estudos populacionais e de segregação. 
Além disso, para o estudo da avaliação de performance do kit, nove indivíduos, 
pertencentes ao pessoal técnico e administrativo do departamento de Diagnóstico do 
IPATIMUP, foram também amostrados, testando-se diferentes materiais biológicos em 
distintos suportes de amostragem. A metodologia adotada e utilizada foi adaptada da 
literatura disponível acerca de casos de validação interna, bem como das diretrizes de 
SWGDAM (Scientific Working Group for DNA Analysis Methods). 
Não foram detetados quaisquer desvios ao equilíbrio de Hardy-Weinberg para os cinco 
novos loci, na população Portuguesa. Na comparação da nossa amostra populacional 
com outras amostras Europeias disponíveis, não foram detetadas diferenças 
significativas ao nível das frequências alélicas. 
Nenhuma inconsistência genotípica foi observada entre os kits ESSplex Plus e NGM 
no estudo de concordância, tal como entre os quatro sistemas multiplex analisados no 
que diz respeito aos marcadores partilhados. 
Comparativamente aos outros sistemas avaliados (NGM, Identifiler Plus e Powerplex 
16 HS) o kit ESSplex Plus revelou uma maior sensibilidade bem como uma melhor 
capacidade de deteção de material genético degradado. 
Os nossos resultados confirmam a robustez do multiplex no que respeita à química da 
reação de PCR, bem como um melhor desempenho, requerido pela comunidade 
forense Europeia para a tipagem de amostras degradadas de modo a assegurar a 
qualidade e sensibilidade dos dados. Os cinco novos marcadores ESS estão 
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adequados para aplicação na nossa casuística de rotina, tal como o kit ESSplex Plus 
como uma opção a ser introduzida na rotina laboratorial. 
 
Palavras-chave: 
ESSplex Plus, Validação Interna, European Standard Set, STRs, Kit de Nova Geração, 
Estudos populacionais, Genética Forense. 
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1. INTRODUCTION 
1.1. Short Tandem Repeat Markers and Commercial Multiplex 
Kits 
1.1.1. Short Tandem Repeat Markers 
The largest portion of the genome is composed of repetitive DNA. Part of this DNA is 
interspersed, with the repeat elements scattered throughout the genome. There are 
different types of repetitive elements, being the most common the short interspersed 
elements (SINEs), long interspersed elements (LINEs), long terminal repeats (LTRs) 
and DNA transposons. The other class of repetitive elements is tandemly repeated 
DNA. This can be separated into three different types: satellite DNA, minisatellites, and 
microsatellites (Goodwin et al., 2011). 
The short tandem repeat (STR) DNA markers are microsatellites and belong to the 
class of  length polymorphisms, being these repeat sequences usually located between 
genes, sometimes intronic and rarely exonic, varying in size from person to person 
(Butler, 2005). 
These kind of markers differ in respect to the repeat structure, since they can be simple 
(Figure 1), compound, complex or even simple with non-consensus alleles (Figure 2). 
The simple repeats contain units that are identical in sequence and length, the 
compound ones contain two or more adjacent simple repeats varying in sequence and 
the complex repeats may present many repeat blocks of variable unit length or variable 
sequences. Furthermore the repeat motifs also differ by the length of the repeat unit: 
dinucleotide repeats are composed of two nucleotides tandemly repeated, 
trinucleotides by three, tetranucleotides by four and so on up to hexanucleotides which 
have six nucleotides in the core motif (Butler, 2005). 
STR markers, introduced into casework in the mid-1990s, are the most commonly 
analysed genetic polymorphisms in forensic genetics (Goodwin et al., 2011), in terms 
of genetic identification and kinship analysis (Butler, 2005). The following properties 
justify this special categorization as forensic markers: 
- Easy and fast amplification by PCR (usually < 400 bp); 
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- High polymorphism and discrimination power; 
- Easy detection; 
- Simultaneous analysis of several STRs, in a single test (multiplex), in automatic 
platforms with fluorescence detection; 
- Multiplex commercial kits available; 
 
 
 
Figure 2 - Structure of different types of short tandem repeat markers. In the simple repeat with a non -consensus 
allele (microvariant), in the example, the 9.3 allele is missing an A from the seventh repeat. The compound repeat is 
composed by several elements. Finally the complex repeat sequence is also represented with non-consensus alleles 
that differ in both size and sequence (Butler, 2005).  
Figure 1 - Structure of a short tandem repeat marker. The core repeat varies between 1 and 6 bp (mononucleotide 
to hexanucleotide) being represented a simple tetranucleotide repeat. The alleles are named according to the 
number of repeats that they contain (Bär W. et al., 1997). 
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There are also STR alleles which may contain some form of sequence variation, 
compared to more commonly observed alleles. They are often called microvariants 
because they have only a slightly different structure from full repeat alleles. Associated 
with this term, usually comes another one, off-ladder (OL) alleles, that refers to alleles 
that often do not size the same as consensus alleles present in the allelic ladder used 
as reference for genotyping samples (Butler, 2005). 
Nowadays, the polymerase chain reaction (PCR) has been employed with unique 
flanking sequence primers to amplify DNA fragments containing STR loci (Sprecher et 
al., 1996). After the amplification process, the length of the products must be measured 
precisely. There was a limitation concerning the number of loci incorporated into the 
multiplexes, due to the allelic size ranges of the different loci, where overlap was not 
allowed. To overcome this fact, fluorescence labelling of PCR products followed by 
multicolour detection has been adopted by the forensic community (Lins et al., 1996, 
Sprecher et al., 1996). Thus, a series of fluorescent dyes has been developed and can 
be covalently attached to the 5’ end of one of the PCR primers in each primer pair. 
Therefore, up to five different dyes can be used in a single analysis which allows for 
considerable overlap of loci (Buel et al., 1998, Ziegle et al., 1992). After analysing the 
raw data with the software, the end result is an electropherogram with a series of peaks 
that represent different alleles: the size, peak height and peak area are also measured. 
During polymerase chain reaction (PCR) amplification of STR alleles, there are 
particular artefacts that can arise and interfere in the correct interpretation and 
genotyping of the alleles present in the DNA template. These stochastic effects may 
give rise to additional peaks besides the true alleles (Butler, 2005). 
In the forensic genetics field, short tandem repeat markers with four or five base-pair 
core-repeat motifs are widely used and the most adopted by the forensic community 
(Bakker et al., 2005). This results from the fact that each STR locus has a tendency to 
generate a stutter product. Stutter is a phenomenon which derives from DNA 
polymerase slippage during PCR (Figure 3) and is dependent on the structure of the 
core repeats: shorter di- and trinucleotide repeats are more prone to stutter than are 
tetra and pentanucleotide repeats (Figure 3) (Bakker et al., 2005). 
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The stutter effect always occurs and reflects the presence of smaller or larger peaks 
than each STR allele, and corresponds to a size difference related to the repeat motif. 
Even if stutters like n-2 and n+1 repeats (among others) may be observed, the most 
common stutter products are one repeat less (n-1) than the corresponding main allele. 
Measuring the percentage of stutter for each locus, may serve as a guideline for the 
detection of mixture samples. In a broad manner, if stutter ratios are introduced in the 
analysis software, this will act as a threshold for calling or not a stutter peak as a true 
allele for a certain locus. Nevertheless there are some parameters that can influence 
the stutter effect, such as the length and sequence inherent to the repeat motif (Applied 
Biosystems, 2011, Qiagen, 2010). 
Another PCR derived artefact is the addition of an extra nucleotide to the 3′-end of a 
PCR product by the DNA polymerases, namely an adenine. This addition is a normal 
event during the copying process of the template strand. When this non-template 
addition occurs it results in a PCR product that is one base pair longer than the actual 
target sequence. If the process is incomplete, then a PCR product with fragment sizes 
Figure 3 - The picture above shows the slippage process between the template and the nascent DNA strands. The 
copied strand represents the most common case and contains one repeat less than the template strand (n-1). The 
stutter peaks are indicated by the arrow and their size relative to the main peak is shown (based on peak area): (a) 
Dinucleotide repeat, which is prone to high levels of slippage. (b) Tetranucleotide repeat, which displays lower levels of 
stutter (Goodwin et al., 2011). 
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differing by one bp will co-exist, named split peaks (+/−A) (Figure 4). This process is 
referred to as ‘adenylation’ or the ‘+A’ form of the amplicon (Clark, 1988). 
 
 
Stochastic events may also be observed when analysing STR markers. Allele drop-out 
is a process consisting in a failure to amplify, and therefore failure to detect an allele 
that exists in the template DNA. It is known that sequence polymorphisms can occur 
within or around STR repeat regions and that these variations can occur in three 
locations (relative to the primer binding sites): within the repeat region, in the flanking 
region, or in the primer-binding region (Figure 5) (Butler, 2005). Even if flanking 
sequences, around STR repeats, are fairly stable and consistent between samples, a 
polymorphism in these regions can result in silent alleles as consequence of primer 
hybridization problems (Kline et al., 2011).  
 
 
 
 
 
 
 
 
Figure 4 - Split peaks are seen in profiles when the non-template addition does not occur with all of the PCR 
products. The three examples show decreasing amounts of non-template addition with panel (a) showing an 
example where the vast majority of PCR product has the non-template addition through to panel (c), where only 
about 50% of the PCR product has the non-template addition  (Goodwin et al., 2011). 
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The drop-out event is also associated to low template DNA analysis, particularly of the 
larger STR loci (Figure 6), and degraded DNA, chemically modified (Goodwin et al., 
2011). 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 - (a) The variation occurs within the repeat region
and should have no impact on the primer binding and the 
subsequent PCR amplification. (b) The sequence variation 
occurs just outside the repeat in the flanking region but 
interior to the primer annealing sites. Again, PCR should not 
be affected although the size of the PCR product may vary 
slightly. (c) The PCR can fail due to a disruption in the 
annealing of a primer because the primer no longer perfectly 
matches the DNA template sequence (Butler, 2005). 
Figure 6 - With 1ng of template DNA, the peaks are well 
balanced and easy to interpret. When the PCR does not 
have enough template to amplify (0.25 ng), then allelic 
drop-out can occur (Goodwin et al., 2011). 
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Allelic drop-in phenomena may also occur. It is mainly observed in low template DNA 
analysis because of contamination from environmental DNA. The main problem 
concerning this effect is related with a difficult interpretation of correct true alleles in a 
degraded or low copy number sample, since the appearance of extra peaks is inherent 
of this phenomenon (Schneider, 2007). 
Another fact concerning STR loci analysis is related to equilibrium of alleles in 
heterozygous state. Two peaks in a STR profile are expected to be balanced in terms 
of peak height and area. However, peak height imbalance is very usual and variations 
in peak height can be due to chance events, where one allele is more efficiently 
amplified than another, for example due to a polymorphism in the annealing zone or to 
the presence of mixtures (real mixtures or contamination cases). Normally, an 
evaluation of the magnitude of heterozygous peaks is made, in order to achieve a 
threshold (peak height ratio), usually around 70% (Gilder et al., 2011), which may serve 
as a guideline for the detection of mixtures or drop-out. 
There is also another phenomenon called pull-up that can emerge from the STR loci 
analysis. Since the dyes used to label amplified DNA fragments are at different 
wavelengths, there is some overlap in the emission spectra of these dyes. If an 
overamplified sample is analysed, this can saturate the matrix and results in a pull-up 
peak of another colour under the main peak. These pull-up peaks need to be 
differentiated from true alleles in order to obtain a correct interpretation, since that other 
colour may also be interpreted as an allele of another locus within the same multiplex 
(Clayton et al., 1998). 
In order to be correctly applied in forensic genetic analysis, STR markers should be 
selected and studied taking into account specific properties, such as artefacts and 
stochastic effects, mutation rates, robustness in PCR, among others. It is also 
necessary to perform a population genetic study, in order to evaluate the behaviour of 
these markers in a particular population sample and their informativeness for forensic 
genetic applications. 
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1.1.2. Commercial Multiplex Kits 
For the evolution and standardization of forensic genetics and for effectiveness of STR 
markers across a wide number of jurisdictions, a pressure was created to select a 
common set of standardized markers. The STR loci that are mostly used nowadays, 
were initially developed in the Dr. Thomas Caskey laboratory’s, at the Baylor College of 
Medicine. Afterwards, Promega Corporation began the commercialization of these 
“Caskey markers” and Applied Biosystems also developed some new STR markers. 
The selection of genetic markers should respect some particular features, namely 
(Goodwin et al., 2011): 
- Be discrete and have distinguishable alleles; 
- The locus amplification should be robust; 
- Should have a high power of discrimination; 
- Should have absence of genetic linkage with other loci being analysed; 
- Enable low levels of artefact formation during the amplification process; 
- Have the ability of being amplified as part of a multiplex PCR.  
 
A commercially available multiplex kit for the forensic field is composed by a set of 
reagents (primers and buffers containing a DNA polymerase amongst other 
components), previously tested by the manufacturer, in what concerns composition, 
quantity and performance, allowing for assurance of reliable results. The first multiplex 
commercial kit was developed in 1994, by Promega Corporation, known as Triplex CTT 
STR Multiplex System and was able to amplify 3 STR markers: CSF1PO, TPOX, and 
TH01 (Budowle et al., 1997).   
After that, a “quadruplex” kit was developed in the UK (United Kingdom) by the 
Forensic Science Service (and commercialized by Applied Biosystems), considered the 
“first-generation multiplex” for forensic analysis. In this multiplex kit 4 STRs were 
amplified in the same reaction: TH01, FES/FPS, VWA and F13A1 (Kimpton et al., 
1994).  
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
9 
 
 
Later, a commercial multiplex kit, known as “second-generation multiplex” (SGM), was 
developed again by the Forensic Science Service (also commercialized by Applied 
Biosystems) and replaced the “quadruplex” system. This multiplex allowed the 
amplification of six polymorphic STRs: TH01, VWA, FGA, D8S1179, D18S51, and 
D21S11 (Goodwin et al., 2011). After this period, with the introduction of fluorescent 
detection platforms, the development of STR kits that allows robust multiplex 
amplification of eight or more loci has revolutionized the forensic DNA field. STR 
profiles are now obtained in just a few hours which is an enormous breakthrough when 
compared with previous methods (for example, RFLP: restriction fragment length 
polymorphism) (Butler, 2005). The AmpF/STR ® SGM Plus ®, developed by Applied 
Biosystems, rapidly replaced the SGM kit and was adopted by many other countries 
around the world as one of their standard multiplex kits (Cotton et al., 2000).   
At this time, in addition to the STR loci, the sex-determining Amelogenin locus, located 
in the X and Y chromosomes, was also incorporated into the most commonly used 
commercial multiplex kits (Thangaraj et al., 2002).  After this, the USA selected 13 STR 
markers to incorporate its database management system named CODIS (Combined 
DNA Index System) and at this time several multiplexes were developed to cover these 
selected markers: CSF1PO, FGA, TH01, TPOX, VWA, D3S1358, D5S818, D7S820, 
D8S1179, D13S317, D16S539, D18S51, and D21S11. Thereby, two major companies 
developed different commercial kits, for example, the AmpFlSTR ® Identifiler (Applied 
Biosystems) and the PowerPlex ® 16 (Promega Corporation), which allow the co-
amplification of these 13 STRs in a single reaction, along with the amelogenin sex-
typing marker and two additional STR loci (Figure 7) (Collins et al., 2004, Krenke et al., 
2002).  
Since that time, both Applied Biosystems and Promega Corporation have developed 
several commercial kits that address the needs of the DNA typing community and 
cover a common set of STR loci with matching probabilities that exceed one in a billion, 
in a single amplification reaction with 1ng or less of DNA sample (Butler, 2005). 
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However, there are also laboratories that develop their own internal multiplexes. This 
kind of approach is time consuming and many resources are spent, which in many 
cases will not compensate the effort. Thus, the convenience of implementing these 
commercial kits is given by the fact that, on one hand, they are conveniently optimized 
and suffer criterious developmental validation and, on the other hand, allow 
opportunities for sharing data between laboratories since available kits determine 
which STRs will be used by the vast majority of forensic laboratories. This 
standardization allows the development of national DNA databases increasingly 
powerful in the forensic genetics field (Butler, 2005, Goodwin et al., 2011). Only very 
recently has a third multinational company started contributing in this field, Qiagen, who 
has proposed a new range of opportunities concerning multiplex forensic kits, trying to 
answer the need for more sensitive, robust, fast and accurate genotyping kits. 
 
Figure 7 - Commercially  available kits for the 13 CODIS core loci: Powerplex®16 and 
Identifiler  (Butler, 2005). The genetic markers surrounded by black lines correspond 
to additional loci. 
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1.2. The new Standard Set of European Genetic Markers (ESS) 
in the forensic field and the Next Generation Kits 
1.2.1. The new Standard Set of European Genetic Markers (ESS) 
On the 25th of June of 2001, the Council of the European Union proposed the first list 
of genetic markers to be used in Europe by the Member States, for judicial purposes, 
respecting the main objectives of the European Union Treaty (February of 1992) and 
the resolution of this Council concerning the exchange of DNA results (June of 1997). 
Taking into account the growing importance of DNA in criminal investigation and the 
use of its effective exchange to oppose criminality, a list of 7 genetic markers was 
proposed (Table 1), composing the ESS (European Standard Set). The Member-States 
would have to adopt them and obtain DNA analysis results by using techniques 
previously validated, with these new loci. These kind of markers, for forensic purposes, 
must be devoid of any information about hereditary specific traits so to be authorized 
their use in the exchange of DNA information between member-states that adopt this 
new set (Union, 2001). 
 
  
 
 
 
 
 
 
 
 
Later, in July 2005, concerning terrorism related subjects, cross-border crime and 
illegal migration, some European countries such as Belgium, Germany, Spain, France, 
Luxembourg, Netherlands and Austria decided to take part in cross-border cooperation, 
in the well-known Convention of Prüm (Germany). In this way, the establishment of 
Table 1 - Composition of the first European Standard Set of Forensic 
Genetic Markers (ESS): D3S1358, VWA, D8S1179, D21S11, D18S51, 
TH01 and FGA. 
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Table 2 - Composition of the current European Standard Set of Forensic Genetic Markers (ESS): left column 
represent the first European Genetic Markers (2001) and in the right column is the new set of forensic genetic 
markers: D1S1656, D2S441, D10S1248, D12S391 and the D22S1045. 
national DNA analysis files had to be created by these members, for the investigation 
of criminal offences and the viable exchange of DNA information. This Convention 
determined the necessary procedures to generate automated searching and 
comparison of DNA profiles as well as issues concerning national contact points and 
technical information of the data (Union, 2005). 
The Council of the European Union decided, in 2008, to implement a new decision 
concerning cross-border cooperation, particularly in combating terrorism and cross-
border crime. The main aim of this decision refers to administrative and technical 
provisions, in particular the automated exchange of DNA data, dactyloscopic data and 
vehicle registration data. Regarding exchange of DNA-data, this decision comes to 
clarify several issues about this matter such as the recommendations for DNA 
database management, including criteria for addition or deletion of DNA profiles, 
matching rules and handling of partial profiles (Union, 2008). 
Most recently, in 2009, on the exchange of DNA analysis results Council and regarding 
all work of the DNA Working Group of the European Network of Forensic Science 
Institutes (ENFSI), for the harmonization of the DNA markers and DNA technology 
across the years, it was proposed a new additional set of forensic genetic markers. 
Taking into account that an effective information exchange is facilitated by increasing 
the number of markers, and that the exchange of DNA data between Member States is 
rapidly progressing, it was necessary to expand the existing European Standard Set of 
loci (ESS) adopted in 2001 and provide more genetic information concerning loci that 
are capable of analysing degraded DNA samples. The European Standard Set (ESS) 
comprises nowadays the following DNA markers (Union, 2009): 
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Once information was available relative to this new set of markers, members of the 
European Union were invited to use, at least, the DNA markers represented in Table 2, 
in order to facilitate an exchange of DNA analysis results. Thus, European members 
were invited to build up ESS analysis results in accordance with scientifically tested 
and approved DNA technology following the studies and frameworks developed by 
ENFSI.  
It should be also remembered that these additional loci are not known to contain 
information about specific hereditary characteristics. If anything concerning this matter 
were to be discovered about a particular locus, member states were advised to no 
longer use that marker in DNA exchanges and also to delete any DNA results received 
(Union, 2009). The new set of five forensic genetic markers was initially characterized, 
concerning technical and specific parameters. 
 
In Table 3 are represented the markers that make part of the extended ESS (European 
Standard Set) and are contained in the main new Next Generation Kits directed for 
European countries: NGMTM and NGM SElectTM kits (Applied Biosystems), 
Powerplex®ESI and ESX Systems (Promega), and ESSplex SE and ESSplex Plus kits 
(Qiagen) (Butler and Hill, 2012). 
 
1.2.2. The Next Generation Kits 
Since national DNA databases are becoming the most powerful tool in forensic 
investigation and genetic identification, and at the same time each country was 
selecting the STR markers that allowed an inclusion in their own database, the ESS 
(European Standard Set) core of loci was created, trying to achieve the standardization 
of forensic genetics across Europe. However, the creation of this new set does not 
Table 3 - Locus – specific information of the new set of forensic genetic markers: D2S441, D10S1248, D22S1045, 
D1S1656 and D12S391 (Butler and Hill, 2012, Lareu et al., 1998, Lareu et al., 1996). 
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mean that European countries should leave the loci that have been using in the 
construction of their national databases in favour of the new ones, but instead they 
would have to adopt and use these new markers in future analysis (Schneider, 2009). 
Regarding this issue, ENFSI and the European DNA Profiling Group (EDNAP) have 
been working together to achieve standardization of DNA profiling throughout Europe, 
with the main purpose of facilitating the comparison of DNA profiles between 
laboratories (Gill et al., 2006a). The intention of these groups was the creation and 
design of multiplexes that could achieve the benefit of criminal justice systems, 
simultaneously increasing detection rates and reducing potential adventitious matches. 
This purpose is thought to be achieved by the adoption of this new set of genetic 
markers, increasing the chance of success in highly degraded samples and the 
discrimination power of all samples tested, since the decrease of amplicon sizes and 
the increase of the number of loci detected will be guaranteed (Gill et al., 2006b). In 
this way, the main goals for the new multiplexes were: 
- Improve the discrimination power with the addition of more loci; 
- Improve sensitivity of testing in order that smaller amounts of DNA may be 
detected; 
- Improve robustness and quality through the more effective amplification of 
degraded DNA (Gill et al., 2006a). 
 
Thus, from the results of collaborative experiments of the ENFSI/EDNAP groups, came 
a need to alter existing multiplexes to improve success rates when degraded DNA is 
analysed (Gill et al., 2006a). In fact, the EDNAP group demonstrated that low 
molecular weight STR loci show benefits in detecting degraded samples since they 
increase the chance of successful amplification by targeting smaller loci (Dixon et al., 
2006). Damage to the DNA molecule can occur through exposure to environmental 
conditions, such as ultraviolet light, heat and humidity. Forensic samples are 
particularly prone to such damage due to their prolonged exposure after deposition 
(Diegoli et al., 2011). Unfortunately, amplicon size and the ability to amplify extremely 
degraded DNA molecules were not considered when the first STR loci were selected. 
Thus, several of them have a large number of repeats or wide allele ranges which are 
not appropriate for generating small amplicons. In this way, leaders of the European 
forensic DNA community recommended the addition of new mini-STR loci (capable of 
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small fragment amplification) to the 13 CODIS markers (Butler, 2006b). As a 
consequence of this study, a convergence of two initial strategies was proposed to 
produce a final product containing 15 loci: in strategy I, mini-STRs (D2S441, D22S1045 
and D10S1248) were added to multiplexes that were already developed, providing a 
multiplex with 13 loci for countries using SGM plus kit. In a second strategy, a second 
group of loci (D12S391 and D1S1656) was preferred by some European countries, to 
be included in the new multiplexes, since these midi-STRs provide a higher 
discrimination power and their size was already reduced. Thus, the convergence of 
these two strategies intended to combine the advantages of strategy 1 and 2, resulting 
in new multiplexes composed, generally, by 15 loci plus Amelogenin. The choice for 
these particular 5 new genetic markers was due to the fact that they are located on 
separate chromosomes or are genetically unlinked from the widely used 13 CODIS 
markers (Gill et al., 2006b). 
Regarding this new multiplex strategy, there was a need to develop commercially 
available kits with these ESS core markers. Concerning this need, the major 
commercial companies in the forensic field started several studies and developmental 
procedures in order to bring to the market the Next Generation Kits and a number of 
STR multiplexes fulfilling the ENFSI and EDNAP objectives. These autosomal kits have 
in common the fact that they share the same core of forensic markers (Figure 8). 
These 12 European core loci are typically accompanied by D16S539, D2S1338, 
D19S433 and SE33 markers (Schneider, 2009). 
 
 
Figure 8 - Graphic representation of the European Standard Set core of genetic markers plus additional markers 
which frequently also composed the Next Generation Kits, shaded in grey (Butler, 2010b). The new  set of genetic 
markers is surrounded with red lines. 
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Nowadays, the validated Next Generation Kits belonging to the three major companies 
are commercially available. However, if laboratories wish to adopt them they must first 
suffer vigorous internal validation, before their introduction in routine casework.     
 
1.3. The Internal Validation Process: history, validation 
guidelines and studies 
It was in the USA, in a few unaccredited laboratories, that some cases emerged where 
DNA analysis was compromised due to several problems, concerning building 
construction, techniques and laboratory personnel inadequately trained. The kind of 
complications encountered resulted later in wrongful decisions of the judicial system, 
illustrating the need for consistent internal quality assurance and external control to 
ensure accuracy within a laboratory (Butler, 2005). Thus, it was decided that any 
scientific procedure, test or product related with DNA typing which results in genetic 
information that may lead to the loss of liberty of any individual involved or not in a 
judicial process, needs to be implemented very carefully. Thereby, in order that this 
sort of process can be conducted properly and since DNA testing is always regarded 
as a powerful investigative tool for the law enforcement community, two main concepts 
were created concerning good laboratory practices and accurate scientific results: 
Quality assurance (QA) and Quality control (QC). QA is related to planned and 
systematic actions that are needed to ensure confidence in a product or service. On 
the other hand, QC is related to the routine operational techniques and the procedures 
used to fulfil requirements of quality.  
Therefore, since these concepts are crucial in the development of forensic DNA 
technology, numerous organizations were established across the forensic community 
in order to recommend and inspect quality assurance guidelines and quality control 
measures (Butler, 2005). 
 
1.3.1. Ensuring Quality: Guidelines and Accreditation 
Validation guidelines for quality assurance programs, in DNA analysis, were first 
published in the USA, more exactly in 1989, when the Technical Working Group on 
DNA Analysis Methods (TWGDAM) was created, under FBI Laboratory sponsorship. 
These validation guidelines were later republished and updated in 1991 and 1995, and 
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in 1998 this organization changed its name to Scientific Working Group on DNA 
Analysis Methods (SWGDAM). Over the years, several subcommittees have 
elaborated numerous recommendations before the SWGDAM, concerning issues 
related to good practices in forensic genetics. In July 2004, SWGDAM published 
revised validation guidelines, being currently the most recent guidelines, and it 
operates nowadays as the responsible group for the recommendations concerning 
quality issues, to the forensic community within the USA (Butler, 2005, Butler et al., 
2004). 
In Europe, the International Society for Forensic Genetics (ISFG),  formerly 
International Society for Forensic Haemogenetics, ISFH), is an international 
organization responsible for the promotion of scientific knowledge in the genetic 
markers field, analysed for forensic purposes, and includes several members from 50 
countries, with a strong impact in Europe. The ISFG has established a Paternity 
Testing Commission (PTC) which is concerned in establishing general standards for 
testing laboratories based on ISO 17025 standards (Morling et al., 2002). However, it 
was in 1995 that the first European organization was created with the responsibility of 
commanding the set of standards for exchange of data, between European member 
states, namely ENFSI (Butler, 2005). 
The European forensic DNA community has another organization, EDNAP, and is 
constituted by a dozen European nations. This organization is, in fact, a working group 
of the ISFG and has been conducting a series of inter-laboratory studies on STR 
markers, investigating the reproducibility of results from multiple laboratories, showing 
that with quality control measures excellent reproducibility can be obtained by these 
groups (Butler, 2005). 
Nowadays, any forensic laboratory which performs DNA tests and analysis for other 
institutions, such as courts or private companies, among others, should undergo an 
accreditation process by an official organization. This process results from a successful 
audit by an accrediting body and requires that the laboratory demonstrates good lab 
practices regarding chain-of-custody and evidence handling procedures. A laboratory 
audit evaluates its entire operation and is conducted by its own laboratory staff (internal 
audit) or by an independent organization (external audit), taking into account pre-
established guidelines. The results and records of each audit must be saved as a way 
to define what can be improved (Butler, 2005). 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
18 
 
 
Proficiency tests are also mandatory and should be performed periodically. A 
proficiency test has the purpose of evaluating a laboratory´s performance in conducting 
DNA analysis procedures, by integrating the laboratory’s normal routine work. Thus, 
these kind of tests also evaluate the ability to obtain a concordant result using the 
standard operating protocols (SOPs) approved for a certain laboratory. Regarding this 
issue, proficiency tests could be internal proficiency tests that are administered by a 
laboratory´s member or external proficiency tests that are administered by an external 
organization. If this sort of test is performed such that the laboratory staff does not 
know that a test is being made, then it is called a blind external proficiency test. This 
blind test is considered the most effective at monitoring a laboratory´s performance. 
Although it can be rather expensive and time-consuming, the participation in 
proficiency – testing programs is a crucial part of a successful laboratory´s quality 
assurance. The main purposes of these tests are the standardization of methods and 
procedures, the standardization of nomenclature, the evaluation of the competence of 
a laboratory to obtain the correct result and the elimination of errors in typing (FBI, 
2008).  
In the accreditation process, one of the main issues is validation of methods. This is 
probably the most difficult and time-consuming task, but it must be undertaken before 
the introduction of any method in routine casework (Butler, 2005). 
 
1.3.2. Validation 
The validation process is an essential part of a quality assurance program in a 
laboratory, when new techniques and technologies are being introduced. This concept 
involves performing specific laboratory studies to verify if a new instrument, software 
program or product is working properly. In other words, a validation study is a process 
where a particular laboratory procedure is considered robust, reliable and reproducible. 
A robust method ensures successful results in a high percentage of the time while a 
reliable method refers to one where the obtained results are correct and reflect the 
samples being tested. Concerning a reproducible method, it represents the ability to 
obtain the same or similar results, each time a sample is tested. It is through the 
validation process that the scientific community acquires the necessary information 
about the conditions, limitations and specificities of a particular procedure (Butler, 
2006a, Butler, 2007). 
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In the validation process there are two different levels that must be considered: 
developmental validation and internal validation. At the developmental validation level, 
the new STR loci or STR kits, new primer sets, new technologies and instruments are 
typically tested and evaluated by the manufacturer of a DNA testing company or by 
large laboratories. Moreover, when a laboratory develops their own methods, they 
should be submitted to developmental validation, such as the “in-house” PCR kits. On 
the other hand, the internal validation consists in verifying if the established 
procedures, previously examined by developmental validation, will work well in a 
particular laboratory. It is an in-house demonstration of the reliability and limitations of 
the procedure, conducted by each forensic DNA testing laboratory (SWGDAM, 2004). 
The constant evolution of new methodologies in DNA testing, the advance of 
technologies and new DNA kits becoming available every day, promotes the need to 
validate and implement new procedures. In fact, if laboratories do not have an outlined 
validation plan, significant amount of time and money could be spent. In fact, the 
consequences of not performing a correct validation study can translate into loss of 
information, wasted resources and money in inappropriate volumes of reagents and 
lack of confidence by the judicial system in DNA proof results. Since reliable analytical 
data, concerning DNA results, is desirable in courts, validation can transmit confidence 
as well as aiding quality assurance in a particularly laboratory (Butler et al., 2004, 
Butler, 2007). 
Therefore, in order to promote appropriate validation studies across European Forensic 
Laboratories, adequate standardization procedures should be defined. However, even 
with the great work that has been made in this direction, there is not yet a standardized 
validation strategy generally accepted or utilized across forensic DNA laboratories. 
There is a wide range of responses throughout the European community, concerning 
the examination of different validation studies, making it difficult to define specific 
recommendations. Nowadays, the most accepted and referenced procedure is the 
SWGDAM recommendations (Butler et al., 2004, Butler, 2007). 
This great lack of standardization across European members, concerning validation 
parameters, allowed the spread of a number of misconceptions regarding validation 
(Butler, 2007). One of the wrong ideas resulting from this issue is precisely the thought 
that the validation process is uniformly performed throughout the DNA community. 
Auditors should understand that variability can always exist among validation studies 
since different perspectives exist. Perhaps as more validation studies and results are 
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completed and shared, a greater uniformity could be established concerning 
approaches, for conducting these studies throughout the human identity testing 
community (Butler et al., 2004, Butler, 2006a). 
Another wrong idea is that the process of learning and training people, regarding a new 
technique, is part of the validation process. It is important to note that instruments are 
calibrated, people can be trained and methods are validated in order to verify if a 
particular process works adequately, when it is performed in a particular laboratory. 
Thus, the idea that hundreds or thousands of samples are required to validate an 
instrument or method is also wrong. The same reliable results and conclusions could 
be achieved with a fewer number of samples. SWGDAM has recommended that, when 
conducting an internal validation, a total of at least 50 samples should be analysed, not 
50 samples per experiment, in order to control the validation process duration (Butler, 
2006a). 
Finally, regarding wrong ideas created around the validation concept, it should be 
reminded that this process does not mimic every situation but instead, it must be 
carefully planned in the different types of experiments that compose it and be used as 
internal additional information (Butler, 2006a). 
 
1.3.2.1. Developmental Validation Studies 
Regarding developmental validation of autosomal commercial kits, mostly performed 
by the respective company or corporation, the usual studies undertaken are indicated 
in bold and briefly described. The other studies mentioned thereafter are also usually 
part of the internal validation process. 
 
- Stability Study 
This test is performed when there is a chance that the DNA analysis, deposited 
on various substrates, be potentially affected by different environmental and 
chemical conditions. In this case, known samples can be used to evaluate and 
determine these possible effects (SWGDAM, 2004). 
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- Species Specificity 
In this study, the potential to detect DNA from forensically relevant nonhuman 
species, for techniques designed to type human DNA, is evaluated. Thus, the 
product that is under validation is studied in terms of the specificity for detecting 
just human alleles. Still, for techniques in which other than human species are 
expected to be targeted, the ability to detect non targeted species is also 
evaluated (SWGDAM, 2004). 
 
- Characterization of loci 
This test can be implemented when the issue under validation involves new 
genetic loci. In this case, topics as the nature of the polymorphism, their 
inheritance, their mapping in the respective chromosome and the evaluation of 
the event of genetic linkage are the most relevant in this analysis (SWGDAM, 
2004). 
 
- Environmental study 
This study uses samples of known genotype and submits them to different 
environmental stresses, such as sunlight exposure, humidity and temperature 
fluctuations. It is supposed to evaluate and verify if the correct genotype is 
always obtained, in a sort of study which reflects the typical forensic cases 
(Butler, 2005, SWGDAM, 2004). 
 
- Annealing temperature studies 
This type of study usually tests a range of different temperatures, concerning 
the annealing process, using a specific PCR system and a genetic analyser to 
evaluate the data. The aim is to establish the optimum temperatures to obtain 
robust profiles and the temperatures where the performance of the reaction is 
compromised. This study is crucial because thermal cycler temperature is 
critical to assay performance (SWGDAM, 2004). 
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- Cycle number studies 
In this study, the number of PCR cycles needed to achieve the adequate 
amount of PCR product is evaluated in a range of different values around the 
optimum number of cycles previously determined. Although it is expected the 
increasing of PCR product amount with more cycles, this test has to take into 
account the nonspecific peaks that can be produced with this increase 
(SWGDAM, 2004). 
 
- Population study 
- Accuracy, precision and reproducibility studies 
- Sensitivity study 
- Stochastic effects study 
- Mixture Study 
 
1.3.2.2. Internal Validation Studies 
When there is need for introducing a new commercial kit in a laboratory’s routine, it has 
to be previously validated in order to understand its behaviour and limitations relatively 
to the space, instruments and techniques that will be used. The range of tests 
conducted for this purpose are not to be strictly followed but instead, they have to be 
seen as auxiliary internal guidelines that can be consulted when some doubt emerges 
in the routine casework. 
The most representative studies that are usually suggested and recommended by 
international organizations are summarized in the following points: 
 
Population Study 
Populations have to be defined in a socio-anthropological context to be able to carry 
out research studies on allele frequency distributions. For example, if the genotype of a 
suspect matches the DNA profile of the evidence, there is still the possibility that this 
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match has occurred by chance. In kinship investigations this sort of study is equally 
relevant.  Therefore, population studies are needed since a powerful DNA database  is 
crucial, with correctly estimated allele frequencies and forensic parameters of interest, 
so that robust conclusions may be achieved (Schneider, 2007). To accomplish this 
task, as a guidance, the analysis of a population sample of about 200 unrelated 
individuals should be representative enough when using these type of markers 
(Applied Biosystems, 2011, Butler, 2005). 
It is also important to confirm Mendelian inheritance of these markers. Autosomal STR 
alleles are known to be codominantly transmitted from parents to their children. Unless 
a mutation or other phenomena take place, it is expected that a child shares one allele 
from each parent. By testing a reasonable set of true trios (mother, father and 
son/daughter), transmission properties may be studied and phenomena such as 
mutation and silent alleles may be detected. 
 
Concordance Study 
This study consists in examining if a given sample, with a known profile, will have the 
same STR genotypes when using a different PCR amplification system, because it is 
expected that there are different sets of primers in the different PCR systems available, 
for each locus. In the evaluation of large sample numbers, variations can be expected 
in primer annealing regions which, in the worst case, can result in silent alleles. Thus, it 
is common to test for the same set of individuals from a population sample, different 
commercial multiplex kits with the same loci (Qiagen, 2010). 
 
Sensitivity Study and Stochastic Effects 
The sensitivity concept could be defined as the ability of a certain system to yield 
correct and reproducible results with a given input DNA. The point where the sensitivity 
of a system is insufficient to detect an allele, although it is present, is defined as the 
limit of detection. The importance of quantification is notorious when just with a dilution 
series of a known sample we can conceive the minimum quantity of input DNA needed 
to obtain a reliable result. Thus, with this study, not only cost-effectiveness may be 
achieved in the long run, since it is expected less need for replications, but also 
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guarantees that results may be reliably interpreted since a balanced profile should be 
always achieved. 
However, with inadequate amounts of input DNA, stochastic effects can emerge. Thus, 
if too much DNA is added to the PCR reaction different types of phenomena can be 
observed, such as the “pull-up” effect, incomplete +A nucleotide addition and a higher 
stutter effect which may compromise the final interpretation. On the other hand, when a 
sample contains very low amounts of input DNA, effects such as unbalanced 
heterozygous alleles, “allelic drop-in” and “drop-out” may be observed (Applied 
Biosystems, 2011, Qiagen, 2010). 
 
Mixture Study 
A mixture can usually be defined by the presence of more than two alleles at a locus, 
the presence of a peak at a stutter position that is greater in percentage than typically 
observed in a single-source sample or even by the presence of significantly 
imbalanced alleles for a heterozygous genotype (Applied Biosystems, 2011). 
Thus, this study intends to evaluate the behaviour of a certain multiplex kit with mixed 
samples. This is mostly important in more complex mixtures where a major and a minor 
contributor are present, where the distinction between the minor component and 
possible stochastic effects is very difficult. Therefore it is important to determine the 
limit of detection of the minor component at which a full profile may be guaranteed. It is 
common practice to use at least two known samples mixed at different concentrations 
in order to evaluate this parameter (Applied Biosystems, 2011, Qiagen, 2010). 
 
Precision Study 
Precision concept involves the determination of accurate and reliable genotypes over 
time. This study consists in measuring the base pair sizes for STR allele amplification 
products. All alleles should be situated within a +/- 0.5 bp window around the measured 
size for the corresponding allele in the allelic ladder. When sample alleles do not size 
within this reference window, the PCR product must be reanalysed in order to 
distinguish between a true off-ladder allele and a measurement error. Precision results 
are typically represented by the standard deviation values of the measured alleles in 
study and it allows for correct identification of a possible microvariant allele (non-
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consensus allele). Thus, it should also be taken into account that sizing differences can 
occur, in the same instrument, due to a number of factors, such as type and 
concentration of the polymer, run temperature and other electrophoresis conditions 
(Applied Biosystems, 2011, Butler, 2005). 
 
Degradation Study 
This sort of study assumes that degraded DNA samples are a common finding in 
forensic genetic cases. The natural process of sample degradation usually comes with 
the decrease in size of DNA fragments that are available to be analysed, due to 
environmental exposure to various kinds of agents. Artificial degradation can always be 
simulated, using procedures that involve the action of DNases, the exposure to UV light 
or even by the process of sonification. Since degraded DNA samples are highly 
represented in routine forensic casework, in degradation studies, the ability of a certain 
set of loci to generate full and reliable profiles is evaluated (Coble and Butler, 2005). 
 
Contamination Study 
This is considered a crucial study, when a new STR profiling system is to be 
implemented.  Its importance resides in the ability of generating an STR profile without 
contamination from an external source. In fact, being the next generation PCR kits 
highly sensitive, they could also be more susceptible to contamination, since very low 
levels of external DNA are now more expected to be detectable. This negative effect 
may arise from handling issues during sample collection, sample handling errors, 
pipetting errors and could result in incorrect assessments of samples and sample 
mixtures. To follow and evaluate this parameter, adequate controls, namely blank 
controls, should be used in all internal validation studies in order to be correctly 
monitored (Qiagen, 2010). 
 
Reproducibility Study 
In this sort of study the aim resides in evaluating and confirming that a same sample 
extracted from different sources or even samples from the same source (e.g. blood, 
semen, oral swab) should always have matching STR profiles (Butler, 2005). 
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2. BACKGROUND AND SPECIFIC AIMS 
The routine casework and activity of IPATIMUP´s laboratory, in kinship and genetic 
identification domains, have nowadays an increased responsibility of an accredited 
space with strict measures of quality control, being evaluated by the annual 
participation in the Proficiency Testings (parentage and forensic), organized by GHEP-
ISFG (Spanish and Portuguese Speaking Working Group of the International Society 
for Forensic Genetics) and in the triannual Proficiency Testing of CAP (College of 
American Pathologists), Parentage/Relationship Testing (PARF) Exercises of paternity 
and forensic challenges, organized by this society. 
The current markers used on a routine basis in IPATIMUP´s laboratory are analysed 
through two multiplex systems, Identifiler Plus (Applied Biosystems) and Powerplex 16 
HS (Promega), which amplify a total of 17 STRs and share 13 loci between them. In 
most parentage investigations, this set is informative enough for a sound conclusion of 
the kinships involved. However, in deficient paternities or in more complex 
relationships, this may not be true. If there is need for more genetic information, the 
laboratory can access to an “in-house” multiplex, composed of 4 loci (CD4, F13A01, 
FES and MBPB), which may aid in obtaining further informativeness. This kit was 
developed many years ago (Alves et al., 2004) with loci that are now rarely used by 
genetic forensic laboratories. As a consequence, participation in proficiency testing with 
these markers will not yield consensus, and so external quality control will not be 
accomplished. Therefore, the need for a new set of STRs became demanding, which 
also would preferably be more informative than the aforementioned “in-house” loci. Of 
course, there are other resources available which may be employed to increase 
informativeness depending on the case, namely autosomal Single Nucleotide 
Polymorphisms [SNPs; e.g. Indels, (Pereira et al., 2009)], Y-chromosome markers (e.g. 
Gusmão and Alves, 2005), X-chromosome STRs (e.g. Gusmão et al., 2012) and 
mitochondrial DNA sequences (e.g. Prieto et al., 2011). However, it is well known that 
autosomal STRs are the most informative markers in the majority of cases which allow 
for a higher power of discrimination. 
On the other hand, since it is more and more common to have casework involving 
degraded DNA samples, it was necessary to implement new markers which would be 
amplified in smaller amplicons. This idea came from the fact that the new European 
Standard Set (ESS) of genetic markers were mostly consisting of mini-STRs and were 
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recently included in commercial kits together with other loci already analysed in 
IPATIMUP´s laboratory. 
Therefore, considering the last recommendations from Europe, it was decided to 
implement these markers in routine casework, thus the necessity to carry out an 
internal validation study of a new generation kit of autosomal markers, the ESSplex 
Plus kit (Qiagen), containing the ESS loci. The choice for this particular commercial kit, 
from Qiagen, was due to our confidence in the consistent and robust results provided 
by Qiagen products, previously experienced in our laboratory, but especially due to its 
attractive price, in comparison to the other available choices. 
Thus, the specific aims of this work were: 
• Re-thinking the laboratory’s strategy: the need for more informativeness (e.g. in 
complex kinships and deficient paternity cases) and evolution to the current 
European standards by incorporation and validation of a new additional set of 
European genetic markers in the Portuguese population. This includes a 
population genetic study for each new STR (allele frequency estimation, Hardy-
Weinberg equilibrium test and parameters of forensic interest) as well as a 
segregation analysis.  
• Internal validation of a next generation kit to be introduced in the laboratory’s 
future routine. Since the actual scheme is based on the simultaneous use of 
Identifiler Plus (Applied Biosystems) and Powerplex 16 HS  (Promega 
Corporation) as an internal quality control measure, the idea would be to 
replace one of these by the new kit, if its performance proved to be better. 
• Increase the genetic information power relatively to degraded samples with the 
adoption of new mini-STRs (amplicons ˂ 200bp), belonging to the new ESS. 
• Contribute to the increase of quality control procedures at IPATIMUP’s 
laboratory and taking the opportunity to validate a greater number of genetic 
markers at a lower cost and with higher power of discrimination, thus improving 
the power of the “in-house” database. 
• Estimate specific thresholds, ratios and investigate about the next generation 
kits performances in order to make this study an auxiliary guide, to be consulted 
in future laboratory analysis. 
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3. MATERIAL & METHODS 
3.1. Sampling strategy 
The sampling process involved choosing an adequate set of samples to use in all 
processes of this work. 
Since this work involved a population genetics analysis and a segregation study for the 
five new ESS loci, 370 DNA samples were selected, comprising 120 true trios (125 
fathers, 125 mothers and 120 sons/daughters). These trios served as the basis for the 
segregation study, and all analyses performed for the population study included the 
typing of the fathers and mothers (250 unrelated individuals living in Portugal). All 
samples derived from these individuals were involved in prior paternity investigations 
and were thus already genetically investigated using the well-established PCR 
multiplex kits Powerplex® 16 HS kit (Promega) and AmpFlSTR Identifiler® kit (Applied 
Biosystems). 
For the more specific internal validation studies, DNA samples were extracted for this 
particular purpose. They were collected from nine technical and administrative 
personnel from IPATIMUP Diagnostics, and different DNA sources were used for each 
individual: blood stains, total blood (Figure 9, a and b); different types of buccal swabs: 
Omni Swab by Whatman (Figure 10a), brush (Figure 10b) and cotton swab (Figure 
10c). 
 
 
 
 
 
 
 
 
 
 
a) b) 
Figure 9 - Two different types of blood sample: a) stain sample (FTA card) and 
b) total blood (liquid). 
Figure 10 - Different models of swabs used in our study: a) Omni-Swab; b) Brush swab and c) Cotton swab. 
a) b) c) 
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3.2. Technical procedures 
3.2.1. DNA extraction 
All collected samples underwent a standard extraction protocol (the Chelex resin 
method) usually used in the laboratory routine and adapted from (Lareu et al., 1994). 
The preparation of samples for extraction involved two main procedures, depending on 
the type of biological material: blood or buccal swabs. 
In the case of blood stains on FTA type paper, the procedure was initiated by cutting a 
square with approximately 3mm x 3mm to a 1.5ml tube. Otherwise, if it were whole 
blood, 10µl was added to a 1.5ml tube. In the next step, 1ml of H2O was added and the 
tubes were incubated for 30 minutes, shaking occasionally. After that, samples were 
centrifuged at 18620 xg (Microcentrifuge Hettich Mikro 200, 14000rpm) for 4 minutes 
and the supernatant discarded by pipetting most of the liquid. Afterwards, 200µl of a 
5% Chelex solution (Chelex 100, 200-400 mesh) was added, with a 1000µl pipette, in 
constant agitation. After mixing the samples in a vortex shaker, they were incubated at 
100ºC, for 8 minutes. Finally the tubes were stirred again in a vortex and centrifuged at 
18620 xg (Microcentrifuge Hettich Mikro 200, 14000rpm) for 4 minutes. The samples 
were then temporarily stored in the fridge (4ºC) if they were to be immediately used. 
Otherwise they would be stored at -20ºC for subsequent utilizations. 
Concerning swab samples, there are some differences in pre-extraction treatment, 
depending on the type of swab. The cotton swab and the Omni Swab have similar 
procedures. The extremities of both types of swabs were sectioned to the respective 
1.5ml tubes and 200µl of 5% Chelex solution were added directly into the tubes in 
constant agitation, with a 1000µl pipette. After that, the samples suffered a small vortex 
shake and were incubated at 100ºC, for 8 minutes. Finally, they were centrifuged at 
18620 xg (Microcentrifuge Hettich Mikro 200, 14000rpm) for 4 minutes and were then 
temporarily stored in the fridge (4ºC). Concerning brush swabs, the main difference in 
the extraction method resides in the fact that the brush swab with the buccal cells is 
taken directly to a 1.5ml tube with ethanol (96%). So first, the tubes had to be 
centrifuged at 14000 rpm for 10 minutes. The excess of ethanol was discarded and the 
tubes with the cellular material were placed, opened, in a hotplate at 70ºC, for 15 to 20 
minutes, until all ethanol had evaporated. After this, the procedures are the same 
comparatively to the other types of swabs: 200µl of 5% Chelex solution added directly 
into the tubes, in constant agitation with a 1000µl pipette. All samples suffered a small 
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vortex shake and were incubated at 100ºC for 8 minutes. They were centrifuged at 
18620 xg (Microcentrifuge Hettich Mikro 200, 14000rpm) for 4 minutes and were then 
temporarily stored in  the fridge (4ºC) (Alves, 2011). 
 
3.2.2. DNA quantification 
DNA samples used for internal validation studies, were quantified by using a Real-Time 
PCR method (RT-PCR), namely the Investigator Quantiplex kit (Qiagen), generally 
according to the manufacturer’s instructions (Qiagen, 2011a). The reaction was run on 
the 7500 Fast Real-Time PCR System (Applied Biosystems). 
This kind of analysis requires the preparation of fresh serial dilutions of the Control 
DNA Z1 sample with the QuantiTect Nucleic Acid Dilution Buffer, both supplied by the 
manufacturer, according to Table 4 (Qiagen, 2011a). 
 
 
 
 
 
 
 
 
 
Thus, standards were serially diluted across a DNA concentration range of 20 ng/µl to 
0.0048828125 ng/µl. The standard curve, consisting of 7 concentration points, is 
always critical for more accurate analysis. 
PCR amplification conditions were first tested in two different final reaction volumes: 
the recommended 25 µl and the optimized 10 µl. In this way, 2.0 µl of DNA sample was 
combined with 23 µl of PCR Master Mix (Reaction Mix plus Primer Mix) for a total 
reaction volume of 25 µl (Qiagen, 2011a), and tested against 0.8 µl of DNA sample 
Table 4 - Serial dilutions of the Control DNA Z1 for quantitation purposes (Qiagen, 2011a). 
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with 9.2µl of Master Mix for a total reaction volume of 10 µl. The latter method was 
chosen and applied to the remaining samples. 
The reaction was prepared in plates with 96 wells, and firmly covered with appropriate 
sealing film. An example of a plate setup of reactions on the Applied Biosystems 7500 
Fast Real-Time PCR System is represented in Table 5 (Qiagen, 2011a). Samples to be 
quantified were loaded in triplicate and a blank (NTC) was always included. 
 
 
 
It is recommended that the standard curve be made from two replicates of each DNA 
Z1 concentration, and this was always carried out. Note that NTC (No Template 
Control) samples should be included in each quantification run in order to detect 
contamination. The NTC samples contain the reagent mix and the QuantiTect Nucleic 
Acid Dilution Buffer. As a control measure, it was also included a DNA sample with 
known quantity: XY13 (2 ng/µl) and 9947A (0.1 ng/µl) were the commercially available 
cell lines included in this study. 
Before starting the RT-PCR, parameters and details must be included in the 7500 Fast 
Real-Time PCR System software (Applied Biosystems, 2010), according to the 
manufacturer’s instructions. The PCR amplification conditions for quantitation were as 
follows: initial hold at 95 ºC for 1 min, followed by 40 cycles of denaturation at 95ºC for 
5 sec and annealing at 60ºC for 25 sec. 
Table 5 - Graphic representation of a possible plate setup for Real Time-PCR reaction using Quantiplex Kit 
(Qiagen, 2010, Qiagen, 2011a). 
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After the RT-PCR occurred (± 40 min.), the results were analysed by the 7500 Fast 
Real-Time PCR System software (Applied Biosystems, 2010) using the 
recommendations included in the Quantiplex User´s Manual (Qiagen, 2011a). 
 
3.2.3. DNA amplification  
Taking into account that the main goal was to simultaneously increase the genetic 
informativeness and make the most economical choice, the option for ESSplex Plus Kit 
(Qiagen) made sense for application in the laboratory’s routine. This Next Generation 
Kit is already an optimized version of the ESSplex Kit (Qiagen) whose chemical 
features were adjusted: the fast cycling technology enables amplification in just 90 
minutes, with a higher sensitivity when compared with the ESSplex version. 
Nevertheless, another next generation Kit was also tested: the NGM Kit (Applied 
Biosystems) was investigated for concordance purposes and also in other validation 
studies. 
Apart from this, Identifiler Plus® kit (Applied Biosystems) and Powerplex® 16 HS kit 
(Promega) were also tested as a means of comparison between performances of 
routinely used kits and the next generation ones. 
Since the four multiplex systems have different components and comprise specific 
methods, the following section describes the PCR procedures involved for each 
commercial kit. 
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Investigator® ESSplex Plus Kit 
 
The characteristics of the genetic markers (loci), that compose this forensic kit, are the 
following (Table 6): 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The recommended volumes of the different PCR components per reaction are 
indicated in Table 7 (Qiagen, 2010). The recommended amount of input DNA for 
ESSplex Plus is 0.5 ng (Qiagen, 2011b). 
 
Table 6 - Specific information about each locus of Investigator ESSplex Plus Kit 
(Qiagen, 2010). 
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The amplification protocol for the ESSplex Plus Kit followed the manufacturer’s 
instructions with the exception of a reduced PCR volume of 10 µl, in a GeneAmp® PCR 
system 9700 (Applied Biosystems). This is routine policy in the laboratory for lowering 
the costs in reagents and other materials. To be sure that this reduction does not 
hamper STR amplification and evaluation, both volumes (10 µl and 25 µl) were 
independently tested. There were no evident differences between 10 µl and 25 µl 
reactions (Qiagen, 2011b). 
The same PCR conditions were always used for this next generation kit (Qiagen, 2010) 
and consisted of the following (Table 8): 
 
 
 
 
 
 
 
 
After this process, the amplified samples were stored at -20º C, protected from light, or 
proceeded directly to electrophoresis. For each PCR reaction that was undertaken, a 
positive control (cell line XY13, supplied by the manufacturer) and a negative control 
(PCR reagents plus sterile water) were analysed. 
Table 7 - Components and respective volumes of the PCR reaction (Qiagen, 
2010). 
Table 8 - Standard cycling program recommended for ESSplex Plus Kit (Qiagen, 2010). 
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AmpFlSTR® NGM™ Kit 
 
Concerning the genetic composition of NGM Kit, it amplifies exactly the same genetic 
markers present in ESSplex Plus Kit. 
Relatively to the amplification reaction, the volume of each component is indicated in 
Table 9. The recommended input DNA for NGM Kit is 1 ng (Applied Biosystems, 2011). 
 
 
 
Once again, the amplification protocol for the NGM Kit followed the manufacturer’s 
instructions, but reducing the PCR final volume to 10 µl, in a GeneAmp® PCR system 
9700 (Applied Biosystems). Both volumes (10 µl and 25 µl) were independently tested 
and there were no evident differences between them.  
A negative and a positive control, namely the cell line 007 supplied by the 
manufacturer, were always added in each PCR reaction. 
Relatively to the thermal cycling conditions (Table 10), the following program was used: 
 
 
 
 
 
 
After this process, the amplified samples were stored at -20º C, protected from light, or 
proceeded directly to electrophoresis. 
Table 9 - Components and respective volumes of the PCR reaction (final volume of 25µl) (Applied 
Biosystems, 2011). 
Table 10 - Standard conditions of thermal cycling program, for NGM Kit (Applied Biosystems, 
2011). 
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Identifiler® Plus Kit 
 
Since this internal validation study aims to evaluate the performance of a new 
generation kit comparatively to the usually used in the laboratory’s routine, the 
Identifiler® Plus Kit was also analysed for comparison purposes. In terms of genetic 
markers, its composition is different from the previous Next Generation Kits. 
The characteristics of the genetic markers (loci) that compose this forensic kit are 
shown in Table 11 (Applied Biosystems, 2012). 
 
 
 
Concerning the amplification reaction, the following table (Table 12) shows the volumes 
of the respective reagents, for a final volume of 25µl. The recommended input DNA for 
Identifiler Plus Kit is 1 ng (Applied Biosystems, 2012). 
 
 
Table 11 - AmpFlSTR® Identifiler® Plus Kit loci, alleles, chromosome location and 9947A positive 
control (Applied Biosystems, 2012). 
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In our studies, the final PCR volume was adapted to 10 µl since both volumes (10 µl 
and 25 µl) were independently tested and there were no evident differences between 
them. A negative and a positive control (cell line 9947A supplied by the manufacturer) 
were added in each PCR reaction. 
Concerning thermal cycling conditions (Table 13), the program used was the following: 
 
 
 
 
 
 
 
 
After this process, the amplified samples were stored at -20º C, protected from light, or 
proceeded directly to electrophoresis. 
 
PowerPlex® 16 HS Kit 
 
Since PowerPlex® 16 HS Kit is the other multiplex kit used routinely in casework, it was 
also analysed for comparison purposes. In Table 14, the PowerPlex® 16 HS System 
Locus-Specific Information is represented (Promega Corporation, 2009 - 2012). 
Table 12 - Components and respective volumes of the PCR reaction (final volume of 25µl)
(Applied Biosystems, 2012). 
Table 13 - Standard conditions of thermal cycling program for Identifiler® Plus Kit; 28 cycles was 
used for all the tests performed (Applied Biosystems, 2012). 
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Concerning the PCR Amplification Mix for the PowerPlex® 16 HS System, the 
information is contained in Table 15: 
 
 
 
 
 
 
 
Table 14 - The PowerPlex® 16 HS System Locus-Specific Information (Promega Corporation, 2009 -
2012). 
Table 15 - PCR Amplification Mix for the PowerPlex® 16 HS System (Promega 
Corporation, 2009 - 2012). 
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The same adoption was made for this multiplex kit concerning the PCR final volume: 
10 µl instead of the recommended 25 µl. A negative and a positive control (cell line 
9947A supplied by the manufacturer) were added in each PCR reaction. 
Relatively to the 9700 thermal cycler protocol for the PowerPlex® 16 HS System Kit, the 
parameters are represented in Figure 11 (Promega Corporation, 2009 - 2012). 
 
 
 
 
 
 
 
 
 
 
 
After the thermal cycling reaction was complete, the amplified samples were stored at -
20ºC, protected from light, or proceeded directly to electrophoresis. 
 
3.2.4. Fragment detection and analysis 
All the amplification products were separated and detected on an ABI Prism 3130 
Genetic Analyser (Applied Biosystems). Genotyping was undertaken using the 
GeneMapper® ID Software v.3.2 (Applied Biosystems, 2005) by comparison to the 
corresponding allelic ladder supplied in each kit. All the multiplex kits panels, bins and 
analysis methods were obtained from the respective companies. 
 
 
Figure 11 - Standard conditions of thermal 
cycling program for PowerPlex® 16 HS 
System Kit (Promega Corporation, 2009 -
2012). 
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Table 16 - Structure of the four multiplexes tested regarding size standard, electrophoresis conditions, amount of input 
DNA and allelic ladder. The * symbol means an adaptation in injection time from 5 seconds to 10. 
 
Regarding electrophoresis conditions (Table 16), the information concerning 
Investigator® ESSplex Plus Kit is described in Table 17 (Qiagen, 2010). The other 
multiplexes (AmpFlSTR® NGM™ Kit, Identifiler® Plus Kit and PowerPlex® 16 HS Kit) 
have exactly the same electrokinetic parameters that were enunciated for ESSplex 
Plus Kit, but an adapted injection time from 5 seconds to 10 was undertaken (Applied 
Biosystems, 2011, Applied Biosystems, 2012, Promega Corporation, 2009 - 2012). 
Regarding sample preparation, all mixes were made at the same proportions: a 10 µl 
mixture at 55:1 proportion: 825 µl Formamide Hi-Di with 15 µl of size standard. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Investigator® 
ESSplex Plus 
Kit 
AmpFlSTR® 
NGM™ Kit 
Identifiler® Plus 
Kit 
PowerPlex® 16 
HS Kit 
Size Standard 550 BTO GeneScan 500 
LIZ 
GeneScan 500 
LIZ 
ILS 600 
Electrophoresis 
Conditions 
Table 17 * * * 
Input DNA 0.5 µl 
 
0.5 µl 0.5 µl 0.5 µl 
Allelic Ladder 1.2 µl 1.2 µl 1.2 µl 1.2 µl 
60 
4840 
5 
15 
180 
3 
10 
20 
15 
60 
15 
1200 
Study values 
Table 17 - Run Module 3kV_10s_500bp for ABI 3130/3130xl and our 
respective internal parameters (Qiagen, 2010). 
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3.3. Validation studies 
3.3.1. Population Study 
For population genetic studies, between 243 and 246 unrelated individuals living in 
Portugal were genotyped using the Investigator® ESSplex Plus Kit (Qiagen, 2011b). 
These samples compose the current IPATIMUP´s database for genetic identification 
and kinship analysis and were previously analysed with Identifiler and Powerplex 16 
systems. 
Allele frequencies were estimated for each of the five new markers (D2S441, 
D22S1045, D12S391, D10S1248 and D1S1656) using GenePop (v.4.1.0) software 
(Rousset, 2010). This software also allowed for assaying the Hardy-Weinberg 
equilibrium through an exact test (Guo and Thompson, 1992). Forensic parameters 
such as expected and observed heterozygosity were calculated according to Nei (Nei, 
1987), and polymorphic information content (PIC), power of discrimination (PD) an d 
power of exclusion (PE) were estimated based on formulas accessed in (Botstein et al., 
1980) for PIC and in (Fisher, 1951) for PD and PE. A comparison was also made 
between our sample (Portuguese population) and other European samples available in 
the literature. For this purpose, the Arlequin Software (Excoffier and Lischer, 2010) was 
used and evaluation of any significant deviations is discussed. 
Moreover, a set of 120 true trios (mother, father and son/daughter) were typed in order 
to test Mendelian inheritance of these five new markers and detect phenomena such 
as mutations and silent alleles. 
 
3.3.2. Concordance Study 
For concordance purposes, 120 unrelated individuals living in Portugal, corresponding 
to the sampled sons and daughters, previously genotyped with Identifiler and 
Powerplex 16 kits, were genotyped with the two different Next Generation Kits: 
ESSplex Plus (Qiagen, 2011b) and NGM (Applied Biosystems, 2011) according to the 
protocols already described. 
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This kind of study allows to evaluate if there is some discordant result for the same 
samples using different kits (comparison of markers shared between them, see Table 
18), with different performances and primer design, and, if there exists, the detection of 
primer binding site mutations that cause silent alleles, or allele drop-out. 
The following figure (Figure 12) represents the procedure designed for our study:  
 
 
 
 
 
 
 
Table 18 - Loci sharing between the multiplex kits analysed. 
Figure 12 - Schematic representation of the concordance procedure. 
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3.3.3. Sensitivity Study, Stochastic Effects and Artifacts 
3.3.3.1. Sensitivity 
In order to evaluate the sensitivity of ESSplex Plus Kit and find the optimal 
concentration of input template DNA, serial dilutions of different types and sources of 
DNA were made: 6 blood samples stained on FTA type paper and total blood in EDTA 
tubes, and 9 swab type samples: Omni Swab (Whatman), brush and cotton, as 
previously described. 
After extracting and quantifying the DNA obtained from each source, serial dilutions 
were performed, with a total of seven different concentrations, ranging from 0.5 ng/µl to 
5 pg/µl.   
The following table (Table 19) shows the concentrations of DNA used in the serial 
dilutions: 
 
 
 
 
 
 
 
 
 
All the serial dilutions were quantified again to ensure greater reliability in our 
procedures.  
Moreover, 5 representative samples were selected and were amplified with the 
Investigator ESSplex Plus, NGM, Identifiler Plus and Powerplex 16 HS kits, in order to 
include the range of DNA values that allows the evaluation of all possible DNA analysis 
effects: drop-out, drop-in, pull-up and full- profile. This analysis resulted from the same 
serial dilutions procedure that was established for the ESSplex Plus. Thus, PCR 
products were run on an ABI PRISM 3130 Genetic Analyser (Applied Biosystems) and 
Serial Dilution Concentration(ng/µl) Diluted DNA Amount(µl) Water Amount(µl)
A [ 31-0.5] - [915-22.5]
B 0.5 15 of A 22.5
C 0.2 15 of B 15
D 0.1 15 of C 15
E 0.05 15 of D 15
F 0.02 15 of E 22.5
G 0.01 15 of F 15
H 0.005 15 of G 15
Original DNA extract 
Table 19 - Example of the procedure designed to obtain a serial dilution of a DNA sample. The letter A 
represents the original samples and are indicated their respective values of initial concentration, which were 
used in this study. 
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all parameters used for electrophoresis were those previously described. Positive and 
negative controls were always included. 
The different kind of samples and DNA concentrations used in this study also allowed 
to evaluate stochastic events and artefacts for the ESSplex Plus kit, namely stutter, 
pull-up, allele drop-in and drop-out and allele imbalance. 
 
3.3.3.2. PHR evaluation 
Regarding allele imbalance, the peak height ratio (PHR) was calculated (Figure 13) 
associated to each loci of the ESSplex Plus, in 33 samples. 
 
Peak height ratio = 			
					()
							()
 
   
 
 
3.3.3.3. Stutter evaluation 
To calculate the stutter ratio for each locus of the ESSplex Plus Kit, 34 DNA samples 
from different sources (blood and swabs) were chosen in a range of [2 ng to 0.5 ng] as 
a means of contemplating the recommended DNA range (Qiagen, 2011b). 
The proportion of the stutter product (Figure 14), relative to the main allele (Stutter 
Ratio), was calculated using the following index: 
 
 
 
 
The 34 samples were selected by taking into account the allelic ranges for each locus 
of the ESSplex Plus kit, in the Portuguese population (Table 20). 
 
 
Figure 13 - Formula used to obtain the PHR values for each loci of the ESSplex Plus Kit. 
Stutter Ratio = 				
			 	!!!	
 
Figure 14 - Formula used for the calculation of the Stutter Ratio. 
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3.3.4. Mixture study 
This study was conducted using a combination of samples from two individuals, both 
laboratory workers (1 male and 1 female). Blood samples were taken from these 
donors and two separate experiments were made in this mixture study. In the first test, 
female and male blood were mixed at increased quantities of female blood to constant 
quantity of male blood, at the ratios indicated in Table 21. In the second mixture 
experiment, the opposite was carried out, as indicated in Table 22. The mixtures were 
prepared across the ranges: 0:1, 1:1, 2:1, 5:1, 10:1, 15:1, 20:1. The 1:0 and 0:1 ratios 
provide the full and clean profile of each input sample used in the mixture analysis and 
act as the reference points. 
 
 
 
 
 
 
Table 20 - Total allelic range for each genetic marker of ESSplex Plus Kit. In red are represented the alleles that 
were present in our selected samples, in the Portuguese population. 
 
Table 21 - Mixture test 1 design: constant male sample 
mixed with increased female sample quantities. 
Table 22 - Mixture test 2 design: constant female 
sample mixed with increased male sample quantities. 
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The reference profiles from the two individuals tested are displayed in Table 23. 
 
 
 
 
 
 
 
 
 
 
 
 
Therefore, for each mixture ratio prepared in 1.5ml tubes, 30 µl of the mixed blood was 
spotted on an FTA type paper. The DNA was then extracted and quantified by RT-
PCR, using the Investigator Quantiplex Kit (Qiagen), and then were diluted to 0.5 ng/µl, 
which corresponds to the input DNA value recommended by Qiagen. 
The PCR amplification design for the mixture study is identical to that of the sensitivity 
study, and was made according to the technical features of the Investigator® ESSplex 
Plus Kit, with the previously mentioned adjustments. After the PCR amplification step, 
samples from both mixture tests were loaded onto the ABI PRISM 3130 Genetic 
Analyser (Applied Biosystems) for fragment detection and data analysis using 
GeneMapper® ID (v.3.2) Software. 
 
 
 
Table 23 - Reference profiles for Mixture 
study: Z codes are related with the internal 
code that is used in our laboratory. 
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Figure 15 - Formula used in the calculation of Mixture Ratio. 
It was also estimated the proportion of contributors present in a certain mixture (Figure 
15). The formula used to obtain this mixture ratio, per loci, was: 
 
 
"#$%&'(	)*%#+ = 	
-&.	+/	-.*00	1(*2-	ℎ(#4ℎ%
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3.3.5. Precision study 
In this study, 33 allelic ladder injections were pooled together to evaluate the precision 
of the Investigator® ESSplex Plus Kit on the ABI PRISM 3130 Genetic Analyser. The 
precision was measured by calculating the standard deviation of the base pair size per 
allele, using the values obtained for each ladder, exported from GeneMapper® ID 
Software (Applied Biosystems, 2005) to the statistical software Microsoft Excel 2010. 
The mean sizes for all the alleles in each run were calculated and the loci with the 
lowest and highest values of deviation were also identified (Qiagen, 2010, Qiagen, 
2012). 
Also, evaluation of precision was done under controlled conditions with 22 ladder 
injections (time, room temperature and electrophoresis parameters, among others), 
and under varying conditions through time, by analysing a total of 11 ladder injections. 
 
3.3.6. Degradation study 
Since the UV-light exposure is a simple and fast method for artificially degrading DNA, 
this was the method of choice for our internal validation study (Bender et al., 2004, 
Thacker et al., 2006). 
We based our study in previously described procedures (Tamariz et al., 2006, Thacker 
et al., 2006), taking into account the type of UV-light (UV-C) and the respective 
wavelength spectrum (100 – 280 nm). For this study, a Mini-V/PCR vertical laminar 
flow bench (Telstar), containing a 254 nm wavelength UV lamp with 15 watts, was 
used. 
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The procedure undertaken was as follows: 
 
I. A DNA sample, previously quantified and diluted to the recommend value 
(0.5ng/µl), was chosen; 
II. 7 tissue slides were cleaned and dried with ethanol; 
III. 10 µl of DNA sample were placed in each slide, approximately in the centre; 
IV. All 7 slides were placed on a support at an approximate distance of 10cm from 
the UV-light lamp, inside the cabinet. All slides were previously identified with 
the sample code and time of exposure; 
V. After turning the UV light on, each slide suffered different times of UV exposure. 
Each slide was removed after turning the UV-light off when the respective 
period of exposure was finished. UV exposure time intervals were the following:  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
VI. After all the samples were removed, the slides were left to dry completely. 10 µl 
of sterilized water were added to each dried stain and mixed thoroughly to 
rehydrate the samples; 
VII. The 10 µl from each slide were transferred to previously identified tubes, for 
future use; 
 
PCR reactions and fragment analysis were undertaken as previously described. 
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3.3.7. Contamination study 
The potential for contamination of a particular multiplex in laboratory routine work was 
evaluated by a contamination study, which comprises the range of tests included in an 
internal validation. 
In this study all the negative (or blank) controls (composed by the mixture of reagents 
and sterilized water) used in all internal validation studies (population analysis, 
concordance, sensitivity, mixture, and degradation) were analysed. The methodology 
used consisted in the detection of any amplified PCR product in these blank controls, 
using the Investigator® ESSplex Plus Kit (N=9) (Qiagen), the NGM (N=8) (Applied 
Biosystems), the Identifiler Plus (N=19) (Applied Biosystems) and the Powerplex HS 16 
(N=11) (Promega Corporation). 
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4. RESULTS AND DISCUSSION 
4.1. Population Study 
A total of 250 unrelated individuals (125 females and 125 males) living in Portugal were 
sampled to be genotyped for the 15 STR loci (D10S1248, D22S1045, D2S441, 
D1S1656, D12S391, D2S1338, D3S1358, D8S1179, D16S539, D18S51, D19S433, 
D21S11, FGA, TH01, vWA) included in the ESSplex Plus amplification kit.  
The population study was focused on the five new loci (D2S441, D22S1045, 
D10S1248, D12S391 and D1S1656), since data was already available for the 
remaining 10 loci (Amorim et al., 2006). 
Allelic frequencies for the five new genetic autosomal markers are shown in Table 24. 
The p-values results confirmed that the frequencies are in Hardy - Weinberg 
equilibrium (p > 0.05), in our Portuguese sample (Table 24). 
Some forensic parameters were also estimated: the expected heterozygosity values 
are comprised in the range of 0.7021 – 0.8979, being the highest value associated to 
the D1S1656 marker (Table 24); relatively to the power of discrimination values, they 
are situated in the range of 0.8603 – 0.9800, being all values superior to 85%. The 
highest value for this forensic parameter is also given by the D1S1656 marker and the 
lowest one by D22S1045 (Table 24). 
Moreover, it is also possible to observe that the power of exclusion range is between 
0.4574 – 0.7897, with the highest value also belonging to D1S1656 and the lowest one 
to D22S1045 (Table 24). 
Overall it is observed that D1S1656 is the most informative marker, since it also shows 
the highest polymorphic information content with an approximate value of 89%. This 
forensic parameter is always above 65% for this set of new forensic genetic markers 
(Table 24). 
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Transmission studies of the five new STRs carried out in a set of 120 true trios (mother, 
father and son/daughter) confirmed Mendelian inheritance. Through this analysis, there 
was no observation of mutations or silent alleles. Even between profiles generated by 
the four different multiplex kits used was there any observation of such phenomena. 
N=number of individuals; Obs.He. =observed heterozygosity; Exp.He. 
=expected heterozygosity; P-value=probability values of the Hardy-
Weinberg equilibrium exact test (50 batches and 10000 interactions); SE= 
standard error of P-value; PIC=polymorphic information content; PD= 
power of discrimination; PE=power of exclusion.             
D1S1656 D2S441 D10S1248 D12S391 D22S1045
9 - 0.0020 0.0020 - -
10 - 0.2082 - - 0.0041
11 0.0535 0.3122 0.0020 - 0.1163
11.3 - 0.0714 - - -
12 0.1296 0.0469 0.0369 - 0.0061
13 0.0700 0.0245 0.2725 - 0.0041
14 0.0967 0.2878 0.3607 - 0.0286
14.3 0.0021 - - - -
15 0.1502 0.0408 0.1742 0.0203 0.3347
15.3 0.0741 - - - -
16 0.1091 0.0061 0.1127 0.0224 0.4041
16.3 0.0556 - - - -
17 0.0432 - 0.0328 0.0833 0.098
17.3 0.1523 - - 0.0305 -
18 0.0103 - 0.0061 0.1951 -
18.3 0.0412 - - 0.0285 -
19 - - - 0.1037 0.0041
19.1 - - - 0.0020 -
19.3 0.0123 - - 0.0244 -
20 - - - 0.1260 -
21 - - - 0.0976 -
22 - - - 0.1199 -
23 - - - 0.0874 -
24 - - - 0.0407 -
25 - - - 0.0122 -
26 - - - 0.0061 -
N 243 245 244 246 245
Obs.He. 0.8971 0.7429 0.7500 0.8618 0.7265
Exp.He. 0.8979 0.7683 0.7517 0.8935 0.7021
P-value 0.7417 0.4182 0.8072 0.3323 0.3774
SE 0.0067 0.0072 0.0088 0.0092 0.0088
PIC 0.8869 0.7306 0.7112 0.8822 0.6505
PD 0.9800 0.9095 0.8986 0.9788 0.8603
PE 0.7897 0.5536 0.5283 0.7828 0.4574
Allele
Table 24 - Allele frequencies and forensic parameters of interest for the 
five STRs D1S1656, D2S441, D10S1248, D12S391 and D22S1045, in 
our Portuguese sample. 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
52 
 
 
A genetic comparison between our Portuguese sample and other European samples 
already available in the literature was also carried out, in order to assess any significant 
deviations that may exist, concerning the five new markers. 
 
D1S1656  
 
Regarding the D1S1656 marker, it is possible to observe, in Figure 16, a homogeneous 
distribution of the allele frequencies across European countries [Spain(Galicia) 
(Formoso et al., 2012),  Basque Country (Yurrebaso et al., 2011), Austria (Dognaux et 
al., 2011), Belgium (Berti et al., 2010), Germany (Seider et al., 2010), Hungary (Martín 
et al., 2007), Italy (Berti et al., 2010), North Italy (Cortellini et al., 2011), Sweden 
(Albinsson et al., 2011), U.K. (Tucker et al., 2011a), Poland (Hatzer-Grubwieser et al., 
2011)]. So, in this case, the comparison of our Portuguese sample with other European 
samples revealed no significant allele frequency differences. 
However, some statistical differences were observed, concerning this forensic genetic 
marker, between Sweden (Albinsson et al., 2011) and Italy (Previderè et al., 2011), and 
between Sweden (Albinsson et al., 2011) and North Italy (Cortellini et al., 2011) 
samples (Figure 17).  
 
Figure 16 - Graphic representation of the allele frequency distribution for the D1S1656 marker, in European samples.
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However, after applying the Bonferroni correction for multiple tests (P < 0.05 / 5 = 
0.01), the data suggests that no significant deviations should be considered. 
 
D2S441  
In respect to the D2S441 marker, the allele frequency distribution is represented in 
Figure 18, for the available European data [North Portugal (Lagoa et al., 2008), Spain 
(Martín et al., 2007), Spain(Galicia) (Formoso et al., 2012), Basque Country (Yurrebaso 
et al., 2011), Austria (Dognaux et al., 2011), Belgium (Berti et al., 2010), Germany 
(Seider et al., 2010), Hungary (Martín et al., 2007), Italy (Berti et al., 2010), North Italy 
 
Number of permutations: 506 
  
Figure 17 - Statistical deviations detected for the D1S1656 genetic marker 
between European samples. 
Figure 18 - Graphic representation of the allele frequency distribution for the D2S441 marker, in European samples. 
 Sweden
 Italy
 North Italy
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(Cortellini et al., 2011), Sweden (Albinsson et al., 2011), U.K. (Tucker et al., 2011a), 
Pol. (Reichert and Pawlowski, 2009), Poland (Hatzer-Grubwieser et al., 2011)]. Also, in 
this case the comparison of our Portuguese sample with other European samples 
revealed, apparently, no significant allele frequency differences. 
Nevertheless, some statistical differences were observed between Poland (Reichert 
and Pawlowski, 2009) and Sweden (Albinsson et al., 2011), Austria (Hatzer-
Grubwieser et al., 2011), Belgium (Dognaux et al., 2011), Italy (Berti et al., 2010), North 
Italy (Cortellini et al., 2011) and U.K. (Tucker et al., 2011a) and also between North 
Portugal (Lagoa et al., 2008) and Sweden (Albinsson et al., 2011) (Figure 19). 
However, after applying Bonferroni correction (P < 0.05 / 5 = 0.01), no deviations were 
considered statistically significant.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19 - Statistical deviations detected for the D2S441 genetic 
marker between European samples. 
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D10S1248 
 
 
 
 
 
 
 
 
 
 
Relatively  to the D10S1248 marker, in Figure 20, it is possible to observe the 
distribution of the allele frequencies between European countries [North Portugal 
(Lagoa et al., 2008), Spain (Martín et al., 2007), Spain(Galicia) (Formoso et al., 2012), 
Basque Country (Yurrebaso et al., 2011), Austria (Dognaux et al., 2011), Belgium (Berti 
et al., 2010), Germany (Seider et al., 2010), Hungary (Martín et al., 2007), Italy (Berti et 
al., 2010), North Italy (Cortellini et al., 2011), Sweden (Albinsson et al., 2011), 
U.K. (Tucker et al., 2011a), Pol. (Reichert and Pawlowski, 2009), Poland (Hatzer-
Grubwieser et al., 2011)]. 
In this case, the comparison of our Portuguese sample (“Portugal”) with other 
European samples revealed great homogeneity. 
However, there were also some statistical differences observed, concerning this 
genetic marker, between Poland (Reichert and Pawlowski, 2009) and Sweden 
(Albinsson et al., 2011) and Poland (Reichert and Pawlowski, 2009) and U.K (Tucker et 
al., 2011a) (Figure 21). However, after applying the Bonferroni correction (P < 0.05 / 5 
= 0.01), the  deviations were considered statistically insignificant. 
 
 
Figure 20 - Graphic representation of the allele frequency distribution for the D10S1248 marker, in European 
samples. 
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D12S391 
 
Concerning the D12S391 allele distribution, in Figure 22, it is also possible to observe 
the homogeneity among European countries [Spain(Galicia) (Formoso et al., 2012),  
Basque Country (Yurrebaso et al., 2011), Austria (Dognaux et al., 2011), Belgium (Berti 
et al., 2010), Germany (Seider et al., 2010), Hungary (Martín et al., 2007), Italy (Berti et 
al., 2010), North Italy (Cortellini et al., 2011), Sweden (Albinsson et al., 2011), U.K. 
(Tucker et al., 2011a), Poland (Hatzer-Grubwieser et al., 2011)]. 
For this locus, no statistically significant differences were observed between all 
European samples. 
 
Number of permutations: 506 
  
Figure 21 - Statistical deviations detected for the D10S1248 genetic marker between 
European samples. 
Figure 22 - Graphic representation of the allele frequency distribution for the D12S391 marker, in European samples. 
 Poland 
 Sweden
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D22S1045 
 
Relatively to the D22S1045 marker, the allele distribution between the European 
countries is represented in Figure 23 [North Portugal (Lagoa et al., 2008), Spain 
(Martín et al., 2007), Spain(Galicia) (Formoso et al., 2012), Basque Country (Yurrebaso 
et al., 2011), Austria (Dognaux et al., 2011), Belgium (Berti et al., 2010), Germany 
(Seider et al., 2010), Hungary (Martín et al., 2007), Italy (Berti et al., 2010), North Italy 
(Cortellini et al., 2011), Sweden (Albinsson et al., 2011), U.K. (Tucker et al., 2011a), 
Pol. (Reichert and Pawlowski, 2009), Poland (Hatzer-Grubwieser et al., 2011)].  Once 
more, this comparison between our Portuguese sample and other European samples 
revealed, apparently, no significant allele frequency differences. 
However, some statistical differences were observed between our sample Portugal and 
Hungary (Molnár et al., 2011) and Portugal and North Italy (Cortellini et al., 2011) 
(Figure 24). 
After applying the Bonferroni correction (P < 0.05 / 5 = 0.01), no deviations were 
considered statistically significant. 
 
 
Figure 23 - Graphic representation of the allele frequency distribution for the D22S1045 marker, in European 
samples. 
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Overall, our findings suggest that there are no significant allele frequency differences 
for the five new genetic markers between our Portuguese sample and the other 
European samples available in the literature. 
Therefore, as expected from several autosomal STR population studies done 
throughout the years on major European samples, these five new markers show an 
overall homogeneous distribution. Moreover, since high values for forensic parameters 
were generally obtained, it may be admitted that these loci will improve significantly the 
discrimination power of IPATIMUP’s internal database for application in kinship and 
genetic identification analyses. 
 
4.2. Concordance Study 
This kind of study allows the observation of any discordant genotype result for the 
same samples using different kits, with different performances and primer design. 
Detection of discrepancies between multiplex kits may be due to silent alleles (primer 
binding site polymorphisms) or the presence of microvariations outside the repeat 
motifs (Alves et al., 2001, Alves et al., 2003, Amorim et al., 2004, Hill et al., 2007). 
Since two of the kits used in this study share the same set of loci, with different primer 
sequences, it was assessed the possibility of any allelic drop-out or null alleles be 
present in the data set. 
In this study, from almost 7200 alleles compared between the ESSplex Plus and the 
NGM systems (2 kits x 15 loci x 2 alleles/locus x 120 samples), full concordance 
between the typing results for the two kits was observed in 100% STR allele calls 
compared. 
 
Number of permutations: 506 
Figure 24 - Statistical deviations detected for the D22S1045 genetic 
marker between European samples. 
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In the concordance process involving Identifiler Plus, Powerplex 16 HS and the 
samples genotyped by ESSplex Plus and NGM kits, full concordance was also 
obtained between these systems for the 8 STR markers (plus Amelogenin) they share. 
 
4.3. Contamination Study 
In order to guarantee reliable analyses, the potential for a possible contamination has 
to be evaluated for the multiplex system used in the laboratory routine. Thus, in the 
contamination study all blank controls amplified with the four different kits (ESSplex 
Plus, NGM, Identifiler Plus and Powerplex 16 HS), during the period involving the 
internal validation laboratory work, were run and noise levels evaluated. This not only 
allowed to verify good laboratory practice, but also to establish the analytical threshold 
(AT) to be used in IPATIMUP’s laboratory casework, particularly important for low 
template DNA interpretation. The AT, expressed in RFUs, is the value where the 
observed peaks below it cannot be reliably distinguished from instrument noise 
(baseline signal) (Butler, 2011a). This threshold has a large impact on DNA fragment 
analysis and interpretation especially when dealing with degraded samples, samples 
containing low-levels of DNA and in complex mixtures. On one hand, if the AT is 
arbitrarily high, true signals will be incorrectly left unlabeled and will be lost during the 
analysis. On the other hand, an AT which is too low will not exclude considerable 
background noise from analysis, increasing the probability that randomly high baseline 
noise be incorrectly detected and labeled as true alleles (Bregu, 2011). 
The contamination study for Identifiler Plus and Powerplex 16 HS was done due to the 
fact that these two systems have already been applied in routine casework. So, a 
comparison between a new option and the routine systems makes sense when the 
goal is to check which of the multiplex kits available may be more reliable or more 
sensitive. Achieving a common AT may also be useful, so that it can be always applied 
independently of the multiplex chosen. 
For many years, the typical values applied by forensic laboratories for the ATs lied 
between 50-200 RFUs. Currently, since all of the new multiplex kits were recently 
designed for increased sensitivity, it is expected to observe a much lower and cleaner 
background noise. Therefore, the typical value applied nowadays for the AT in the 
forensic community, varies between 30 RFU – 50 RFU (Butler, 2011b, Butler, 2012, 
Coble, 2012, Sivak, 2011). 
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After evaluating all the blank controls studied in this work, it was decided that it was 
reasonable to establish the 30 RFU limit as the AT for all four multiplex kits. In all 
cases, the typical baseline level appeared around the 10 RFU threshold, with some 
noise peaks close to 20 RFU, and rarely few above this threshold (Figure 25 - 28). In 
low template DNA interpretation, it is important to maximize allele detection while at the 
same time minimize the false labeling of noise. The 30 RFU threshold seems 
conservative enough and sufficiently broad enough to accomplish this and allow 
standardization in STR allele interpretation. 
 
 ESSplex Plus 
 
 
 
Figure 25 - Typical result of a blank control amplified with the ESSplex Plus system. 
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NGM 
 
Identifiler Plus 
 
Figure 26 - Typical result of a blank control amplified with the NGM system. 
Figure 27 - Typical result of a blank control amplified with the Identifiler Plus system. 
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 Powerplex 16 HS 
 
 
4.4. Sensitivity Study, Stochastic Effects and Artefacts 
Before performing any other analysis involved in internal validation procedures, and 
since it is usually difficult to predict the amount of DNA after extraction, all DNA 
samples were quantified, using RT-PCR, by applying the recently introduced kit 
Investigator Quantiplex from Qiagen (Qiagen, 2011a). 
In order to get a clear idea of the sensitivity of multiplex kits and since most stochastic 
effects are DNA input dependent, a robust quantification procedure is a fundamental 
tool for obtaining more precise results. 
The kit chosen (Investigator Quantiplex, Qiagen) for the RT-PCR process has 
demonstrated high sensitivity and reproducibility in our study. It was used in 
IPATIMUP’s laboratory for the first time during this study. The reaction is based on the 
amplification of a small fragment with 146 bp, being this region present on several 
autosomes of the human genome. Detection of amplification is performed using 
Scorpion primers and a novel, fast PCR chemistry. Scorpion primers are bifunctional 
molecules containing a PCR primer covalently linked to a probe. The fluorophore in this 
probe interacts with a quencher, also incorporated into the probe, which reduces 
Figure 28 -Typical result of a blank control amplified with the Powerplex 16 HS system. 
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fluorescence. During PCR, when the probe binds to the PCR products, the fluorophore 
and quencher become separated. This leads to an increase in fluorescence in the 
reaction tube (Qiagen, 2011a). One of the advantages of this quantification kit is that it 
contains an internal control, 200bp, which is designed to be more sensitive to inhibitors 
than the human quantification target. The comparison of the CT value of the internal 
control system for DNA standards with the CT values of the internal control system for 
unknown samples may provide an indication of potential inhibition of the reaction in the 
unknown samples. This allows the detection of the presence of inhibitors in DNA 
samples, which in turn may compromise the multiplex STR PCR which follows (Qiagen, 
2011a). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 29 - Example of a graphic representation of the quantification results, concerning Standard Curve, Amplification 
Plot, Multicomponent plot and Raw Data Plot. 
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In Figure 29, the most important parameters of a standard curve are represented, as 
an example of the usual results that were obtained: the slope, the Y-intercept, the R2 
value and the efficiency. Relatively to the slope, it describes the PCR efficiency and 
typically ranges between -3.0 to -3.6. A value of -3.3 indicates 100% PCR efficiency, 
meaning that the number of copies of amplification product is doubled at each cycle 
(Qiagen, 2011a). 
The R2 value is a measure of the fit of the data points to the regressed line and usually 
the standard curve has an R2 value ≥ 0.990. Moreover, the Y-intercept value is just an 
indication of the CT  (threshold cycle) value for a sample with Qty = 1(ng/µl) (Qiagen, 
2011a). 
Concerning the standard curve, it is expected that variability will occur in the 
quantification process of a same sample in different RT-PCR reactions. Therefore, the 
quality of the standard curve produced is important for obtaining reproducible and 
reliable results, and so caution must be taken to ensure that control DNAs for standard 
curve construction are well prepared.  On the other hand, since guaranteeing 
equivalent standard curves in different RT-PCRs is almost impossible, it is fundamental 
to include in each reaction a control DNA sample with known DNA quantity. In this way, 
deviations between RT-PCR quantifications are more easily detectable. 
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4.4.1. Sensitivity 
According to the ESSplex Plus Handbook (Qiagen, 2011b), the recommended input 
DNA for optimal results should be between 0.2 – 0.5 ng. Previous studies available 
through a developmental validation document, made by Qiagen (Qiagen, 2012), 
demonstrated that reliable results may be obtained with < 0.1 ng DNA. The aim of the 
analyses undertaken in this work was to check whether these recommendations held 
true for the type of samples routinely processed at IPATIMUP’s laboratory.  
DNA samples from different sources were serial diluted to obtain seven different 
concentrations (ranging from 0.5 ng/µl to 5 pg/µl), amplified and run according to the 
procedure already described. In Fig. 30 an example is shown of the results obtained 
from the ESSplex Plus kit with one of these serial dilutions. 
Data was analysed by observing the overall performance throughout the decrease in 
DNA input. Stochastic effects such as allele imbalance, drop-out and drop-in, as well 
as artefacts such as stutter and pull-ups were measured, and genotypes were 
analysed by two approaches: visual and threshold. The “visual approach” is here 
understood as an EPG interpretation made by an experienced technician/researcher 
where no thresholds or reference values are taken into consideration, whilst the 
“threshold approach” is based on reference values, namely stutter and peak height 
ratios, an analytical threshold (AT) previously estimated and a stochastic threshold 
(ST), which are incorporated in the GeneMapper® ID Software v.3.2. analysis software 
(Applied Biosystems, 2005). 
Note that the stochastic threshold delimits a peak height window where stochastic 
effects may be expected to occur. Above this peak height value, it is reasonable to 
assume that allelic drop-out of a sister allele of a heterozygote has not occurred at that 
locus, so single alleles above this value in single-source samples are assumed to be 
homozygous (Butler, 2012). According to (Butler, 2006c), this threshold is situated 
around 150 – 200 RFUs (Puch-Solis et al., 2011, Gill et al., 2009). 
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0.5 ng 
0.2 ng 
0.1 ng 
0.05 ng 
0.02 ng 
0.01 ng 
0.005 ng 
Figure 30 - Example of an electropherogram of a random sample analysed with ESSplex Plus kit. In 
this picture, the range of values experimented in the sensitivity test (from 0.5 ng/µl DNA to 0.005 
ng/µl) is represented. Note that the y- axis scale was magnified for the smaller input amounts of 
DNA. 
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The absence of stochastic effects, together with the clear observation of balanced 
profiles and absence of pull-ups, determined the optimum amount of input DNA. This 
visual approach, applied on five different serial dilutions of samples from different 
sources, determined that full profiles for the ESSplex Plus kit  are obtained down to 0.1 
ng/ µl, since drop-out is observed for concentrations below 0.1 ng/ µl, which is 
consistent with what is indicated by the kit’s reference values (from developmental 
studies). 
Since at 1 ng/µl a slight pull-up effect was observed, the maximum recommended DNA 
concentration for reliable interpretation of genetic profiles was established to be 1 ng/µl. 
In this way, the optimum value estimated for input DNA was 0.5 ng/µl, where stochastic 
effects such as allele imbalance, drop-out and drop-in were absent, being in 
accordance with Qiagen recommended value (Qiagen, 2010, Qiagen, 2012). 
 
4.4.2. PHR evaluation 
After knowing the optimum DNA input, the peak height ratios (PHR) for all loci of the 
ESSplex Plus kit were estimated. Qiagen considers this value to be at 70% for all loci 
(Qiagen, 2012). However, due to individual compositions and inherent features of each 
genetic marker, it was considered relevant to estimate this parameter individually 
(Budowle et al., 2009). Thus, heterozygous peak heights were measured; the average 
and standard deviation (SD) for each locus were obtained and finally applied the 
formula Average – SD to obtain the individual result for each one of the genetic 
markers (Figure 31). 
 
 
 
 
 
 
 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The Amelogenin locus has no systematic bias that favours the amplification of Y and X 
alleles.  
Since every locus has a PHR ≥ 70% (Figure 31), it can be admitted that above this 
value, two heterozygous alleles can be grouped as a possible genotype (Butler, 2012). 
Usually, when the smaller of two peaks is less than 70% of the height of the larger 
peak at a locus, the disparity in peak heights is typically taken to be an indication that 
there is more than one contributor of template DNA to the sample. On the other hand, if 
the smaller of two peaks is equal to or greater than 70% of the height of the larger peak 
at a locus, that is consistent with the proposition that they may have come from a single 
contributor (Gilder et al., 2011). This shows the relevance of this parameter in order to 
better evaluate cases where mixtures can be present (Gehrig et al., 2011).  
Although this threshold is in accordance with Qiagen’s recommendations, it is 
important to remember that each locus has an individual behaviour, especially when 
using this ratio for mixtures analysis. 
Figure 31 - Peak height ratio (PHR) resulting 
from (average – SD), in percentage, for each 
ESSplex Plus locus. 
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4.4.3. Stutter evaluation 
In this study the stutter effect was evaluated concerning all loci of the ESSplex Plus Kit. 
The stutter ratio (%) was estimated per allele per locus according to (Budowle et al., 
2009), taking into account that it was not possible to cover the whole allelic range of 
each marker since each population has a particular allelic range. 
Thus, a reference stutter value per locus was identified by taking the mean of each 
locus plus three times the SD (Applied Biosystems, 2011), in order to be useful 
especially for future mixture analysis. 
The results obtained are represented across graphic distributions of the percentage of 
stutter peak detected against each locus allelic range, and are shown through Figures 
32 to 46. 
 
 
 
 
 
 
 
Figure 32 - Distribution of stutter values across the allelic range of the TH01 marker, in ESSplex Plus kit. Estimation of a 
a reference stutter value. 
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Figure 33 - Distribution of stutter values across the allelic range of the D3S1358 marker, in ESSplex Plus kit. Estimation 
of a reference stutter value. 
Figure 34 - Distribution of stutter values across the allelic range of the vWA marker, in ESSplex Plus kit. Estimation of a 
reference stutter value. 
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Figure 35 - Distribution of stutter values across the allelic range of the D21S11 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 36 - Distribution of stutter values across the allelic range of the D16S539 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
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Figure 37 - Distribution of stutter values across the allelic range of the D1S1656 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 38 - Distribution of stutter values across the allelic range of the D19S433 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
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Figure 39 - Distribution of stutter values across the allelic range of the D8S1179 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 40 - Distribution of stutter values across the allelic range of the D2S1338 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
74 
 
 
 
 
 
 
 
 
Figure 41 - Distribution of stutter values across the allelic range of the D10S1248 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 42 - Distribution of stutter values across the allelic range of the D22S1045 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
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Figure 43 - Distribution of stutter values across the allelic range of the D12S391 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 44 - Distribution of stutter values across the allelic range of the FGA marker, in ESSplex Plus kit. Estimation 
of a reference stutter value. 
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Figure 45 - Distribution of stutter values across the allelic range of the D2S441 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
Figure 46 - Distribution of stutter values across the allelic range of the D18S51 marker, in ESSplex Plus kit. 
Estimation of a reference stutter value. 
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The range of stutter values (%) detected for this study, for the ESSplex Plus loci, was 
[9% - 21%], showing the heterogeneous behaviour inherent to each marker (Table 25). 
 
 
 
 
 
 
 
 
 
 
 
In this study it was also observed that the sequences and sizes of the STR alleles 
influence the stutter rates. Therefore, as expected, it was generally observed that the 
stutter effect increases with the increase of allele size for each locus (Brookes et al., 
2011). 
Relatively to the repeat motif behaviour, in respect to their size, the D22S1045 locus 
(the only trinucleotide marker) has a high stutter value of 21%. This also confirms that 
the stutter effect is influenced by the size of the repeat motif, as is well known. The 
other markers, which are all tetranucleotide motifs, generally showed values of stutter 
lower than D22S1045. 
The recommended stutter ratio values available from Qiagen (developmental studies) 
were compared with the values obtained in this internal validation study (Figure 47). 
Note that Qiagen uses the mean stutter ratio for each locus so, in order to compare 
with our study, the stutter ratios presented in Figure 47 correspond to the mean stutter 
ratio values. 
Table 25 – Reference stutter values 
estimated for the ESSplex Plus loci, 
using the formula x + 3SD. 
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The method employed in our study for locus stutter ratio determination (mean plus 
three times SD) allows for a more conservative approach especially when analysing 
mixture samples with GeneMapper ID v. 3.2. In Qiagen developmental studies, just the 
mean values are presented, without any statistical correction, being this sort of 
approach not recommended (Mulero et al., 2008). Ideally, the best method would be to 
employ individual stutter ratios for each allele at each locus in a specific multiplex kit. 
 
4.4.4. Sensitivity comparison between multiplex kits 
Since the recent next generation kits are said to have enhanced sensitivity, it seemed 
important to compare the sensitivity data obtained with the ESSplex Plus kit not only 
with the sensitivity results from the routine STR kits already employed in the laboratory 
(Identifiler Plus and Powerplex 16 HS), but also with the results obtained from direct 
ESSplex Plus competitors, like the NGM kit. 
The serial dilutions of the samples used for the ESSplex Plus sensitivity study were 
also amplified with NGM, Identifiler Plus and Powerplex 16 HS kits. The results 
obtained are shown through Figures 48 to 55 and the comparison between methods 
and kits are discussed. 
As mentioned earlier, the profiles obtained were analysed by two approaches: visual 
and threshold. As a reminder, the threshold approach is based on reference values, 
Figure 47 - Comparison between developmental mean stutter ratios and internal mean stutter ratios obtained in this 
study, for each locus of the ESSplex Plus kit. 
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namely stutter and peak height ratios previously estimated; the same analytical 
threshold (30 RFU) and stochastic threshold (150 RFU) were applied for all kits in the 
analysis of the genotypes. Note that at IPATIMUP’s laboratory the ST has already been 
established as 150 RFU and seemed appropriate to apply this value in this work. 
The analysis from both perspectives for the ESSplex Plus kit, (Figure 48 and Figure 
49), revealed that the threshold approach is the most conservative, due to the more 
restrictive values involved (30 RFU for AT, 150 RFU for ST , the previously estimated 
values of stutter and PHR). In this approach, the drop-out effect emerged earlier, at 0.1 
ng/µl (Figure 49), compared with the visual approach, at 0.05 ng/µl (Figure 48). 
 
 
Concerning the other parameters, the pull-up effect is considerably detected at values 
equal or above 2 ng/µl, where the difficulty in results interpretation may be greater. 
Nevertheless, this effect was also detected in samples with 0.5 ng/µl and, although this 
could constitute an exception, this isolated event has to be taken into account when 
analysing routine casework (Figure 48 and Figure 49). The drop-in effect was only 
detected at DNA input levels < 0.02 ng/µl. 
Figure 48 - Sensitivity results of the ESSplex Plus Kit, concerning visual approach. Parameters such as 
complete profile, drop-out and pull-up were evaluated. 
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The ESSplex Plus kit allowed the detection of complete profiles until 0.1 ng/µl using the 
visual approach (Figure 48) and 0.2 ng/µl using the threshold approach (Figure 49). 
 
 
 
 
 
 
 
 
 
 
 
 
With the threshold approach, it is clear that nearly half of the profile information is lost 
at 0.1 ng/ µl, much sooner than in the visual approach. 
Concerning the NGM kit, both approaches revealed similar results for each parameter 
studied (Figure 50 and Figure 51). 
 
 
 
 
 
 
 
Figure 49 - Sensitivity results of the ESSplex Plus Kit, concerning threshold approach. Parameters such 
as complete profile, drop-out and pull-up were evaluated. 
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Nevertheless, this system revealed a premature detection of allele drop-out (at 0.1 
ng/µl), which can indicate a worse performance compared to ESSplex Plus. Thus, 
complete profiles were only guaranteed until 0.2 ng/µl. 
The pull-up effect appeared at values above 2 ng/µl. Relatively to the drop-in effect, it 
was only detected at 0.01 ng/µl of DNA. 
 
Figure 50 - Sensitivity results of the NGM Kit, concerning visual approach. Parameters such as complete profile, 
drop-out and pull-up were evaluated. 
Figure 51 - Sensitivity results of the NGM Kit, concerning threshold approach. Parameters such as complete 
profile, drop-out and pull-up were evaluated. 
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Concerning the Identifiler Plus kit, the drop-out effect was detected even earlier (0.2 
ng/µl) using both methods (Figure 52 and Figure 53), allowing for complete profiles to 
be obtained only after 0.5 ng/µl of input DNA. 
The pull-up effect was only detectable for values equal or above 2 ng/µl (Figure 52 and 
Figure 53) and drop-in was just present at 0.01 ng/µl of input DNA. 
 
 
With Identifiler Plus, both perspectives showed similar performances. However, it was 
clearly visible the lower sensitivity of this system when compared with ESSplex Plus 
and NGM kits. 
Figure 52 - Sensitivity results of the Identifiler Kit, concerning visual approach. Parameters such as complete 
profile, drop-out and pull-up were evaluated. 
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Finally, when the Powerplex HS 16 system was evaluated, the drop-out effect was 
detected at 0.2 ng/µl (Figure 54 and Figure 55) using both perspectives. 
 
 
 
 
 
 
 
 
 
 
Figure 53 - Sensitivity results of the Identifiler Kit, concerning threshold approach. Parameters such as complete 
profile, drop-out and pull-up were evaluated. 
Figure 54 - Sensitivity results of the Powerplex HS 16 Kit, concerning visual approach. Parameters such as 
complete profile, drop-out and pull-up were evaluated. 
FCUP 
Establishing the European Standard Set of forensic genetic markers in routine casework: 
population studies and next generation kit internal validation 
84 
 
 
The pull-up effect was detected for values greater than 0.5 ng/µl inclusive, although it 
was not observed above 3 ng/µl in the samples analysed. Drop-in was observed at 
0.01 ng/µl of input DNA, with an isolated event at 0.1 ng/µl. 
 
 
Overall, the drop-out phenomenon showed particular patterns. In a total of 20 drop-out 
events detected in the set of the 5 samples for the 4 multiplex systems, the D2S1338 
marker was present in 11 events (55%), which is expected since this marker has the 
largest amplicons of the whole set. Also Powerplex 16 HS system had, essentially, 
three markers (Penta E, Penta D, and CSF1PO) as the first loci to suffer drop-out. In all 
cases, there is clear correlation between higher fragment size and more prone to allele 
drop-out. 
In summary, after analysing the four multiplexes, the ESSplex Plus and the NGM kits 
showed better results and more sensitivity when compared with Identifiler Plus and 
Powerplex 16 HS, commonly used in routine casework. Thus, ESSplex Plus and NGM 
kits seem to be the selected systems when a more sensitive and reliable analysis is 
needed, concerning, for instance, cases of degraded and low copy number samples. 
Figure 55 - Sensitivity results of the Powerplex HS 16 Kit, concerning threshold approach. Parameters such as 
complete profile, drop-out and pull-up were evaluated. 
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Moreover, through the serial dilutions performed with different samples sources (whole 
blood, blood stains, buccal swabs), at optimum concentrations of input DNA, it was 
possible to verify the reproducibility of the ESSplex Plus Kit, in the achievement of the 
same genetic profile across several PCR reactions of the same sample (obtained 
through different biological materials and different means of sample collection) and also 
in the achievement of reproducible balanced profiles. 
 
4.5. Mixture Study 
The increase in sensitivity has a consequent effect on mixture analyses, namely on the 
detection of minor mixture components. In these experiments, the ability of detecting 
the minor component was studied for the ESSplex Plus kit by determining the lowest 
mixture ratio at which the full profile of the minor component can be identified as well 
as determining at which mixture ratio it is possible to detect a mixture profile, according 
to the parameters used for this evaluation (more than two peaks per locus and peak 
height imbalance). 
The results obtained by mixing samples from two individuals (male and female) in 
different proportions were evaluated taking into account the peak height ratio of 70%, 
the individual loci values of stutter and the AT (30 RFU) previously determined and 
incorporated in the GeneMapper ID analysis software (Figure 56 and Figure 57).  
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F:0 
F:1 
F:2 
F:5 
F:10 
F:15 
F:20 
Figure 56 - Electropherogram of the experiment where increasing amounts of male DNA were mixed with 
constant female DNA in the following ratios: F:0, F:1, F:2; F:5, F:10, F:15 and F:20. 
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M:1 
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M:10 
M:15 
M:20 
Figure 57 - Electropherogram of the experiment where increasing amounts of female DNA were mixed with 
constant male DNA in the following ratios: M:0, M:1, M:2; M:5, M:10, M:15 and M:20. 
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Concerning the analysis of mixtures ratios of increasing male DNA to constant female 
DNA, the analysis software determined a full profile of the minor component (female) at 
the 1:5 ratio. The analysis of the mixture ratios of increasing female DNA to constant 
male DNA revealed that a full profile of the minor component (male) was possible until 
the 1:2 ratio. In Figure 58, the electropherogram of the mixtures from 1:5 to 1:10 are 
shown for the blue fluorochrome to illustrate the loss (allele not called) of the minor 
contributor full profile. In the same way, concerning Figure 59, the electropherogram 
represents the mixtures from 1:2 to 1:5, for the yellow fluorochrome, illustrating also the 
loss (allele not called) of the minor contributor full profile.  
 
 
F:5 
F:10 
Figure 58 - Electropherogram of the mixtures from 1:5 to 1:10 are shown for the blue fluorochrome to illustrate the 
loss of the minor contributor full profile. The red arrow shows the allele not called by the Analysis Software. 
M:2 
M:5 
Figure 59 - Electropherogram of the mixtures from 1:2 to 1:5 are shown for the yellow fluorochrome to illustrate the 
loss of the minor contributor full profile. The red arrow shows the allele not called by the Analysis Software. 
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The ability of detecting a mixture profile by the analysis software is summarized in 
Table 26. 
 
 
By evaluating all loci together, it is possible to detect clear mixture profiles at ratios of 
1:20 (Table 26), for female or male constant DNA, according with the established 
parameters for mixture detection (more than two peaks per locus and peak height 
imbalance) and using the GeneMapper ID’s analysis parameters.  
As can be seen in Figure 58 and Figure 59, it is clear that some extra peaks are 
present although the software does not call them as alleles, because they are either at 
stutter positions or below the 30 RFU threshold. This emphasizes that mixture 
interpretation, at levels where major and minor contributors are very disproportionate, 
an application of a fixed stutter ratio is too conservative and valuable information will be 
lost, since alleles from the minor contributor will not be called. This study emphasizes 
that it is important to follow the current guidelines in mixture interpretation, stating that 
in mixtures with low level of a minor contributor, the alleles from the minor contributor 
may be in stutter positions of the major contributor, and should not be disregarded (Gill 
et al., 2006a, Moretti et al., 2001). 
The locus by locus independent evaluation approach showed some isolated events 
between specific mixture ratios, which are depicted in Table 26 as red letter Y. In some 
cases, for example, the loss of the minor contributor detection at 1:15 ratio was 
Table 26 - Mixture study results concerning two different analysis: female DNA constant with an increase of male 
DNA and male DNA constant with an increase of female DNA. Y (Yes) means a positive detection of mixture and N 
(No) an absence of mixture event. The red letters represent specific and isolated events. 
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recovered again at 1:20. This may be due to the fact that PCR has different efficiencies 
and also that electrophoresis conditions vary considerably, namely injection efficiency. 
This mixture study also allowed to better understand the relative ratio of DNA 
contributions from two individuals to a mixed DNA typing result. The use of quantitative 
peak height information can be used to calculate the mixture ratio (Butler, 2010a) from 
loci containing the maximum number of alleles (four alleles in mixtures from two 
unrelated individuals). 
 
 
Mixture ratios can help deduce contributor profiles (Butler, 2010a, SWGDAM, 2010). In 
Table 27 it is possible to observe that when mixture ratios reached high levels of 
disproportionality (equal or higher than 1:10) it becomes very difficult to achieve a 
reliable proportion of contributors. The red values represent ratios with the highest 
deviation from the real mixture ratio. The peak height ratio of Amelogenin locus was 
estimated in order to observe the behaviour of this marker in a possible male/female 
mixture. As expected, when the male DNA was constant with an increase in female 
DNA, the imbalance in this locus was progressively higher (from 1:1 to 20:1). On the 
other hand, concerning the other experience where female DNA was constant with an 
increase in male DNA, the Amelogenin had an imbalance increasingly smaller (1:1 to 
20:1). 
 
4.6. Precision Study 
Accurate and reliable genotypes can be obtained by sizing precision studies. The 
method that has been recommended for this kind of analysis (Applied Biosystems, 
Table 27 - Mixture ratios obtained using the five available heterozygous loci. The average of these mixture ratios is also 
represented as well as the peak height ratio concerning Amelogenin locus. 
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2011) is to employ a ±0.5-nt “window” around the size obtained for each allele in the 
Investigator® ESSplex Plus Allelic Ladder. 
This study was made taking into account the fact that when GeneMapper® ID Software 
automatically flags an allele that does not size within the prescribed window around an 
allelic ladder, labelling it as OL, this has to be confirmed, if in doubt, by repeating the 
analysis and not only considering the precision sizing values obtained in this internal 
validation work. 
This experiment evaluated the allele size variances obtained from multiple injections of 
the allelic ladder and assessed the use of GeneMapper® ID Software (v.3.2) on 
designating alleles. Data for each allele was analysed by determining their sizes in 
base pairs and the average and SD for each locus of the ESSplex Plus was calculated. 
In this study two different perspectives were analysed: under controlled conditions and 
unintentionally varying conditions. The latter results were mainly from room 
temperature fluctuations during time, but also from other factors such as variations in 
ABI routine maintenance. 
The charts for each locus (below) exhibit SD bin sizes for each allele within that locus 
(Sgueglia et al., 2003). 
 
 
Figure 60 - Precision results for the study in controlled conditions, where all loci of the ESSplex Plus kit were 
analyzed together, with respect to their allele sizes and SD. 
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Maximum sizing precision is obtained within the same set of capillary injections with 
fewer changes in the involved conditions. In this way, concerning the study where the 
conditions were apparently controlled (Figure 60), there seems to exist a relation 
between the increasing of the dispersion with increasing size of the marker. It was also 
relevant the fact that the maximum SD was lower than the 0.5 bp reference value, 
which demonstrated very good precision with bin sizes approximately equal to or less 
than 0.32 bp (maximum SD was approximately 0.319 bp for the FGA locus). The FGA 
locus was responsible for the highest sizing differences as already mentioned in other 
studies (Applied Biosystems, 2011, Sgueglia et al., 2003). The locus with the lowest 
average SD was Amelogenin with 0.050 base pair deviation. 
However, sizing differences occur due to a number of factors including different 
polymer lots, run temperature, electrophoresis conditions, and room temperature. 
Therefore, it was also evaluated a set of ladder injections performed on different days 
in week spans, where different conditions are expected (Figure 61). The results show 
that there is also a relation between the increase of the dispersion and the increase in 
marker size. However, the maximum SD reflected in uncontrolled conditions occurred 
substantially above the 0.5 bp recommended window (maximum SD was 
approximately 1.215 bp in the FGA locus) (Figure 61). The locus with the lowest 
average SD was TH01 with 0.081 base pair deviation (Figure 61). 
 
 
Figure 61 - Precision results for the study in uncontrolled conditions, where all loci of the ESSplex Plus kit were 
analyzed together, with respect to their allele sizes and SD. 
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Figure 63 - Precision results for TH01, D16S539, D10S1248 and D2S441 markers. These distributions resulted 
from the study where values of the controlled and uncontrolled experiments were considered. 
In Figure 62, all ladder injections are graphically represented in both situations: 
controlled and uncontrolled studies. 
Thus, taking into account all the results obtained for ESSplex Plus system, caution is 
needed especially when larger alleles of particular loci (such as FGA) are interpreted, 
in order to avoid mistakes concerning, for instance, mistaking variant alleles for on-
ladder ones (Sgueglia et al., 2003).  
Individual analysis regarding the set of loci that compose the ESSplex Plus kit was also 
performed, in order to detect any peculiarity in what concerns precision behaviour vs 
size and/or structure. 
Figure 62 - Precision results for the study with uncontrolled and controlled conditions, where all loci of the ESSplex 
Plus kit were analyzed together, respecting their sizes and SD. 
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In Figure 63, the smaller sized loci from ESSplex Plus kit are represented. This set of 
markers showed a more homogeneous behaviour, less disperse and with a more 
proportional distribution than larger loci, which is most probably due to their fragment 
size. 
 
 
 
In Figure 64, the loci in the range of 130 – 240 bp are shown. Approximately after 
170bp is the point where the precision values exceed the 0.5 bp recommended. 
Therefore, represented by the white colour are the values below the 0.5 bp window and 
the red colour represents the values that are above. There are also values symbolized 
by yellow points where the marker distribution changes. There is a dispersion decrease 
observed at D3S1358, D1S1656 and D18S51 around 180-190bp (no D22S1045 alleles 
analysed at this range), and it increases again after the 200bp point (shown by 
D18S51). There is no evident explanation for this behaviour for all the loci in this size 
range. 
 
 
 
Figure 64 - Precision results for D3S1358, D1S1656, D22S1045 and D18S51markers. These distributions 
resulted from the study where values of the controlled and uncontrolled experiments were considered. 
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In Figure 65, a particular behaviour concerning the D19S433 and the D12S391 loci can 
be observed. More exactly at the 240 – 260 bp range, these two markers show a 
marked decrease in the dispersion event (yellow points). Since this decrease is 
followed by a new increase in the dispersion values, an isolated effect must be 
associated. In this case, a possible explanation for the smaller dispersion detected at 
this size range may relate to the size standard (550 BTO, Figure 66) which at this point 
has fragments with a 10 bp interval instead of the usual 20 bp interval present 
throughout this size standard. 
 
 
 
Figure 65 - Precision results for VWA, D19S433 and D12S391 markers. These distributions resulted from the 
study where values of the controlled and uncontrolled experiments were considered. 
Figure 66 - Electropherogram of the DNA Size Standard 550 (BTO), fragments with lengths in bp (Qiagen, 2011b).
The 240 – 260 bp range is delimited as an example of 10 bp intervals in the 550 BTO size standard. 
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In Figure 67, three loci in the same size range with similar behaviour in their distribution 
are shown. These markers reflect the dispersion behaviour at higher size ranges. Here, 
it is evident the direct proportional relationship between dispersion increase and 
increasing size of the marker. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 67 - Precision results for D21S11, D8S1179 and FGA markers. These distributions resulted from the 
study where values of the controlled and uncontrolled experiments were considered. 
Figure 68 - Precision results for D2S1338 marker. This distribution resulted from the study where 
values of the controlled and uncontrolled experiments were considered. 
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In Figure 68, the dispersion concerning the D2S1338 marker is represented, which is 
markedly different from other markers of the ESSplex Plus system. The D2S1338 locus 
shows a completely different dispersion since, concerning its size (380 to 440 bp), it 
would be expectable to observe an increase of its dispersion values through the allelic 
range. It is difficult to find an explanation for this marked decrease in the dispersion 
values, since it is not known if any single factor is causing this effect. Although this is 
the only marker mainly inside the size standard region where sizing fragments have a 
25bp interval, this would not explain lower dispersion; on the contrary, larger dispersion 
would be expected. 
This new next generation kit used with the 550 BTO size standard has revealed the 
precision requirements necessary to conduct forensic DNA analysis using an allelic 
ladder to size the unknown fragments. In the same way as in all multiplex PCR kits, it 
requires the repeated use of the allelic ladder in several runs, since temperature 
fluctuations, along with other factors, interfere with electrophoresis runs.  If severe 
temperature fluctuations exist, as well as changes in other conditions, it is advisable to 
run an allelic ladder in each run (Sgueglia et al., 2003).   
 
4.7. Degradation Study 
In order to evaluate the newly developed miniSTR systems, tests were conducted on 
artificially degraded DNA samples, for the four different multiplex kits: ESSplex Plus, 
NGM, Identifiler Plus and Powerplex HS 16. The first two systems present the 5 new 
loci which are frequently announced as new potential loci for analysis of degraded 
DNA. 
Since AmpFlSTR® NGM™ kit has the same mini-STR loci as Investigator® ESSplex 
Plus kit, a comparative analysis was made in order to evaluate the performance and 
capability of detection of the maximum genetic information content, consisting in the 
evaluation of the number of heterozygotes detected.   
Nevertheless, Identifiler® Plus Kit and PowerPlex® 16 HS Kit were also tested for this 
validation study since it seems crucial to evaluate the performance of the smaller 
genetic markers incorporated in these multiplexes which are currently in use in the 
laboratory, and if, in fact, the 5 new mini-STRs present in the recent kits do make a 
difference. 
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Therefore, the behaviour of the four systems were evaluated and compared in order to 
observe if some advantage exists in the use of ESSplex Plus or NGM systems. This 
approach gave us a better ability to choose the autosomal kit that may provide us more 
genetic information, in better conditions, for our routine work. 
The method of analysis consisted in the evaluation and identification of the 
heterozygous loci that were amplified with DNA UV exposed from 0 to 20 minutes, in 
the following time intervals: 20’’, 40’’, 1’, 3’, 10’, 15’ and 20’. The maximum time of 
exposure that our sample underwent corresponds to the recommended time of 
exposure for DNA decontamination in laminar flow or PCR cabinets. 
The analysis of data was also done using both approaches, previously established: 
visual and threshold approaches. The heterozygous loci number, across the 
degradation time range, were converted to a percentage value to facilitate comparison 
between the four systems analysed (these are composed by a different number and 
type of loci). With the visual approach, these heterozygous loci were selected, 
independently of any threshold. On the other hand, with the threshold approach, only 
the heterozygous loci that were selected by the software of analysis were considered. 
Concerning the comparison between the two different approaches, the threshold 
approach demonstrated more conservative results since it revealed lower percentages 
of heterozygous loci detected. Also, with this sort of approach, there is greater 
heterogeneity of values among the different multiplexes, for each UV exposure time 
(Figure 70). 
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Figure 69 - Degradation study results concerning the visual approach. The percentage of heterozygous loci 
detected across the time range of degradation exposure was calculated for the four multiplexes in study. 
Figure 70 - Degradation study results concerning the threshold approach. The percentage of heterozygous loci 
detected across the time range of degradation exposure was calculated for the four multiplexes in study. 
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Concerning the comparison between multiplex system performance and regarding the 
visual approach, the greatest loss of heterozygous loci happened at different 
degradation times. For the Identifiler Plus and Powerplex HS 16 kits, at 40 seconds of 
UV exposure there was a loss of 50% of the initial amount of heterozygous loci (Figure 
69). On the other hand, for ESSplex Plus and NGM kits, the same loss only happened 
at 3 minutes of exposure (Figure 69). 
Therefore, the ESSplex Plus and NGM systems presented, through the visual 
approach, a higher degree of informativeness in comparison with Identifiler Plus and 
Powerplex HS 16, and a similar degree between them regarding the number of 
heterozygous loci detected. These two kits are also the only that ensure some kind of 
genetic information above the 15 minutes of UV exposure (Figure 69). 
Still, concerning the Identifiler Plus and Powerplex kits, not only did they show a more 
rapid loss of heterozygous loci but also did not allow for any genetic information at 15 
and 20 minutes of UV exposure (Figure 69). 
With the threshold approach, the degradation effect among these four systems 
followed more or less the same behaviour. However, the NGM kit was unable to ensure 
any genetic information at 20 minutes of UV exposure (Figure 70), unlike the visual 
approach, and it can be clearly shown a better performance for the ESSplex Plus 
system. Therefore, the ESSplex Plus kit, in this study, is the only system capable of 
delivering heterozygous detection at the highest level of degradation (20 minutes), and 
is the system that gives generally the highest genetic information throughout the 
degradation process Figure 71. 
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Figure 71 - Example of an electropherogram of a random sample submitted to different times of UV-light 
exposure analysed with ESSplex Plus kit. In this picture, the values of time exposure, experimented in the 
degradation test (from 0 seconds to 20 minutes), are represented. Note that the y- axis scale was magnified 
for the smaller input amounts of DNA. 
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20 min. 
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5. CONCLUSIONS 
Nowadays, Human STR genotyping for forensic analyses and population studies is 
currently done with commercially available autosomal STR multiplex kits, the majority 
of which amplify a minimum of 15 markers in a single PCR. However, a new ESS of 
forensic genetic makers was proposed to be adopted across the European scientific 
community. In this way, the internal validation study of a new next generation kit, 
having this new set, is critical in order for it to be applied in the laboratory’s forensic 
casework. The kits currently used, Identifiler Plus and Powerplex 16 HS, lack these 
new five ESS STRs and so a new multiplex kit must be implemented and substitute 
one of the latter. The ESSplex Plus kit was primarily chosen for this goal, since Qiagen 
has demonstrated consistency and robustness in their products throughout the years 
and have shown very competitive prices in their recent launch of human identity 
products. 
The validation of the five new loci in the Portuguese population revealed no deviations 
from Hardy-Weinberg equilibrium. The robustness of forensic parameters concerning 
this new set and the increased discrimination power provided by this new ESS will also 
assist in paternity testing and complex relationship elucidation. It will allow improving 
the power of the “in-house” database whilst evolving to the current European 
standards. 
The comparison of our Portuguese sample with other European samples, available in 
the literature, generally revealed no significant allele frequency differences for the five 
new loci. This implies, on one hand, that genotyping was well carried out and, on the 
other hand, that a general European database could be used and information 
exchange throughout Europe can be correctly accomplished. It is important to note that 
ensuring the same nomenclature and robust laboratory techniques across European 
population studies is important and over the years this has been aided and achieved 
through robust commercial multiplex kits.  
In fact, despite using different primer sequences, 100% concordance between the 
same 15 autosomal loci in ESSplex Plus and the NGM system was demonstrated. 
Through the contamination study, it was possible to estimate a common Analytical 
Threshold of 30 RFU for ESSplex Plus, NGM and the two previously used multiplex 
systems, showing a marked improvement at the baseline level. 
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Two different approaches were used for analysing genotype data. The visual approach, 
where the expert’s experience is the only opinion that counts, showed different results 
when compared with the threshold approach, where analytical and stochastic 
thresholds are applied as well as estimated parameters of stutter and peak height 
ratios. This was expected in the same way as it was expected that this last approach 
would reveal to be more conservative. This demonstrates and confirms that if the visual 
approach were to be carried out by more than one expert, the results would most 
certainly be different and difficulty in defining a final interpretation would occur. It 
confirms the advantages of using thresholds to facilitate interpretation bias, although it 
should be emphasized that this will most probably lead to loss of genetic information. In 
fact, when dealing with mixtures with clear minor contributor(s), the threshold approach 
will undoubtedly eliminate that information. 
The ESSplex Plus was designed for maximal sensitivity under the cycling conditions 
recommended for these multiplexes and for robust amplification in the presence of high 
levels of common PCR inhibitors. Under recommended cycling and injection conditions 
ESSplex Plus kit showed more sensitivity compared to NGM kit and the routinely used 
Identifiler Plus and Powerplex 16 HS systems. Thus, optimal profile balance was 
achieved at 0.5 ng of input DNA, which is in accordance with Qiagen’s recommended 
values. The ESSplex Plus kit also demonstrated a higher capability in genetic 
information detection, at lower levels of DNA amount. 
The individual estimation of stutter ratio values for each ESSplex Plus locus will 
contribute to improve mixture analysis. The mixture of two contributors in this study 
demonstrated that the capability of this system in detecting the minor contributing 
alleles is at 1:20 ratios. The evaluation of the power of this system in estimating the 
ratio of DNA contributors to a mixed DNA typing result when two contributors are 
involved, revealed that in mixture ratios equal or higher than 1:10 it is difficult to 
achieve a reliable proportion of contributors. 
The precision results concerning ESSplex Plus system has shown that electrophoretic 
mobility is totally dependent on environment fluctuations over time, and allele sizing 
and designation may be compromised. The allele precision behaviour for each STR 
that was studied revealed that, apart from some isolated cases, in general, smaller 
sized loci have more precise sizing than larger loci; that smaller alleles in a locus will 
have more precision than larger ones; and that there is also a strong influence in the 
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size standard in what concerns its fragments size intervals (i.e. smaller intervals will 
lead to more precision). 
Degraded samples amplified with ESSplex Plus system in this study highlighted than 
an improved recovery of genetic information can be achieved compared with the 
remaining multiplexes (NGM, Identifiler Plus and Powerplex 16 HS). The success of 
the ESSplex Plus system in this study can be attributed, in part, to improved sensitivity 
(Tucker et al., 2011a) plus the increased number of mini-STRs. 
The internal validation studies presented here illustrate the improved performance of 
the ESSplex Plus multiplex compared with the standard Identifiler Plus and Powerplex 
16 HS, routinely used. 
Future analysis using ESSplex Plus kit as one of the multiplex systems incorporated in 
forensic casework routine should provide, by the use of real time PCR quantification 
analysis, a better management of the input DNA used as well as the laboratory 
reagents involved. 
Since the internal validation study has been completed, IPATIMUP’s laboratory of 
genetic identification and kinship analysis has now the ability to develop internal 
interpretation guidelines based on the results of all the studies carried out. Therefore, 
along with the developmental validation study performed by Qiagen, these internal 
validation studies provide concrete information about ESSplex Plus performance, 
which can be a useful tool in future DNA analysis (Tucker et al., 2011b). 
Results of our validation study demonstrates that the ESSplex Plus kit is a reliable 
multiplex, which may be suitable for use on all types of forensic samples, since it has 
shown throughout this work to have robust PCR chemistry and improved performance, 
requested by the European forensic community for typing degraded samples and 
ensuring reliable results. 
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